Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.
A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to four weeks old are the most severely affected.
Spherical RNA viruses, in the order NIDOVIRALES, infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS.
Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Respiratory tract diseases are a broad range of medical conditions that affect the nose, throat, windpipe, and lungs, impairing breathing and oxygen uptake, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, influenza, tuberculosis, and sleep apnea.
Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.
Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild.
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.
Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
A pathological accumulation of air in tissues or organs.
Inhaling and exhaling the smoke of burning TOBACCO.
Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.
Disease having a short and relatively severe course.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
Inflammation of the NASOPHARYNX, usually including its mucosa, related lymphoid structure, and glands.
Persistent abnormal dilatation of the bronchi.
Measurement of volume of air inhaled or exhaled by the lung.
Virus diseases caused by CORONAVIRIDAE.
The volume of air that is exhaled by a maximal expiration following a maximal inspiration.
Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
Any hindrance to the passage of air into and out of the lungs.
The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.
'Coal mining' is not a medical term, but it refers to the process of extracting coal from the ground by mechanical or manual means.
Any combustible hydrocarbon deposit formed from the remains of prehistoric organisms. Examples are petroleum, coal, and natural gas.
Earth or other matter in fine, dry particles. (Random House Unabridged Dictionary, 2d ed)
Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.
The aggregate business enterprise of manufacturing textiles. (From Random House Unabridged Dictionary, 2d ed)
Endoscopic examination, therapy or surgery of the bronchi.
Diseases caused by factors involved in one's employment.
Pathological processes involving any part of the LUNG.
A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
Increased RESPIRATORY RATE.
A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers.
Analogs and derivatives of atropine.
The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.
Welding is not typically considered a medical term, but rather refers to a process in manufacturing and construction involving the joining of metal components through heat or pressure, which isn't directly related to medicine or healthcare.
Inflammation of the BRONCHIOLES.
Substances that reduce the growth or reproduction of BACTERIA.
Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
Tracheitis is an inflammation of the trachea, often caused by viral or bacterial infections, characterized by symptoms such as cough, sore throat, and difficulty swallowing.
The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation.
X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest.
Infection of the lung often accompanied by inflammation.
A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
The rate of airflow measured during a FORCED VITAL CAPACITY determination.
Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Methods and procedures for the diagnosis of diseases of the respiratory tract or its organs. It includes RESPIRATORY FUNCTION TESTS.
The presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS.

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. (1/165)

In this study we aimed to estimate direct medical costs of Chronic Obstructive Pulmonary Disease (COPD) by disease type; chronic bronchitis and emphysema. This study estimates direct costs in 1996 dollars using a prevalence approach and both aggregate and microcosting. A societal perspective is taken using prevalence, and multiple national, state and local data sources are used to estimate health-care utilization and costs. Chronic bronchitis and emphysema together account for $14.5 billion in annual direct costs. Inpatient costs are greater than outpatient and emergency costs ($8.3 vs. $7.8 billion) and hospital and medication costs account for most resources spent. The high prevalence of chronic bronchitis accounts for its larger total costs ($11.7 billion) compared with emphysema ($2.8 billion). Emphysema, which is more severe, has higher costs per prevalent case ($1341 vs. $816). Hospital stays account for the highest costs, $6.0 billion for chronic bronchitis and $1.9 billion for emphysema. The hospitalization rate, length of stay and average cost per prevalent case are higher for emphysema than for chronic bronchitis. Medication costs are the second highest cost category ($4.4 billion for chronic bronchitis, $0.693 billion for emphysema). The high hospitalization and low home care costs (0.2% of total) suggest underuse of home care and room to shift from acute to preventive care. More attention to healthcare management of chronic bronchitis and emphysema is suggested, and improving inhaler and anti-smoking compliance might be important targets.  (+info)

Heat shock proteins mRNA expressions by peripheral blood mononuclear cells in asthma and chronic bronchitis. (2/165)

OBJECTIVE: To investigate the manifestations that heat shock proteins(HSPs) possess in the pathogenesis of asthma and chronic bronchitis. METHODS: Using reverse transcription-DNA polymerase chain reaction (RT-PCR), we investigated the expression levels of HSP70, HSP90 alpha and HSP90 beta genes in peripheral blood mononuclear cells(PBMC) at natural state and after heat shock in 14 healthy volunteers, 21 patients with asthma and 18 patients with chronic bronchitis. RESULTS: No HSP70 gene but HSP90 alpha and HSP90 beta expressions were found in non-heat-shocked PBMC of normal control; HSP90 alpha and HSP90 beta genes may be expressed in PBMC of patients no matter whether they were in acute episode or not. Expression of HSP70 was found in PBMC of patients in acute episodes and of three symptoms-free patients with Aas 3, step 2. No expression of HSP70 gene was found in PBMC of patients in convalescent period but in PBMC of patients in acute episode. HSP90 alpha and HSP90 beta genes were expressed in PBMC of the two patients groups; After heat shock, expressions of the three genes increased in amount significantly in PBMC of all normal controls and patients. CONCLUSION: Expression of HSP70 gene in PBMC of asthmatic patients and chronic bronchitis was different, indicating that HSPs, especially HSP70 might be involved in the pathogenesis of asthma.  (+info)

Sleep as a teaching tool for integrating respiratory physiology and motor control. (3/165)

Sleep exerts major effects on most fundamental homeostatic mechanisms. Current data suggest, however, that students of physiology and medicine typically receive little or no formal teaching in sleep. Because sleep takes up a significant component of our life span, it is proposed that current teaching in systems and integrative physiology is not representative if it is confined to functions describing wakefulness only. We propose that sleep can be readily integrated into various components of physiology and medical curricula simply by emphasizing how commonly taught physiological processes are importantly affected by sleep mechanisms. In our experience, this approach can be used to reinforce basic physiological principles while simultaneously introducing sleep physiology into the students' training. We find that students have a general and inherent interest in sleep and related clinical disorders, and this proves useful as an effective means to teach the material. In this paper, examples of how sleep influences motor control and the respiratory system will illustrate these points. These considerations also highlight some important gaps in traditional teaching of respiratory physiology.  (+info)

Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? (4/165)

The use of antibiotics in acute exacerbations of chronic bronchitis (AECBs) remains the subject of controversy despite considerable medical and socioeconomic implications. First, the contribution of bacterial infection to AECBs is difficult to assess in patients with chronic obstructive pulmonary disease (COPD) who are chronically colonized with respiratory pathogens. In addition, several studies suggest a major role of viral infections in AECBs. Secondly, it is unlikely that all COPD patients will benefit from antibiotics during AECBs. In particular, the benefit in mild COPD remains uncertain. Unfortunately, the number of studies complying with evidence-based medicine requirements is too small for definite recommendations in AECBs to be drawn up. Considering the impact of acute exacerbations of chronic bronchitis on chronic obstructive pulmonary disease patients, as well as the community, and the impact of antibiotic therapy on the development of bacterial resistance, there is an urgent need for the design of appropriate multicentric studies to define the usefulness of this type of treatment in acute exacerbations of chronic bronchitis.  (+info)

Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. (5/165)

BACKGROUND: Sputum analysis is used increasingly to assess airway inflammation in patients with chronic obstructive pulmonary disease, including those with chronic bronchitis and bronchiectasis. However, it is not known whether dithiothreitol (DTT), a reducing mucolytic agent regularly used to homogenise sputum, affects the detection of inflammatory mediators in the sputum soluble phase from such patients. METHODS: Thirty two spontaneous sputum samples were collected from 13 patients with chronic bronchitis and 17 with bronchiectasis. An aliquot from each sample was treated with either freshly prepared 0.1% DTT plus normal saline (NaCl) or NaCl alone, then ultracentrifuged to obtain the sputum sol phase. Interleukin (IL)-1beta, IL-6, IL-8, leukotriene B(4) (LTB(4)), secretory leukoprotease inhibitor (SLPI), alpha-1-antitrypsin (alpha(1)-AT), and tumour necrosis factor alpha (TNFalpha) were measured by ELISA, and neutrophil elastase (NE) and myeloperoxidase (MPO) by chromogenic substrate assay. The effect of DTT on the detection of assay standards was also determined. RESULTS: Median levels of IL-1beta, IL-6, IL-8, SLPI, and NE were similar in the DTT and NaCl treated samples. There was a significant reduction in median (IQR) levels of detectable TNFalpha (0.07 (0.00-0.47) pM v 0.90 (0.06-6.98) pM, p<0.001), LTB(4) (1.67 (1.31-2.64) nM v 2.29 (0.95-4.22) nM, p<0.05) and MPO (0.00 (0.00-0.00) mg/l v 4.48 (0.00-33.66) mg/l, p<0.001) and a small increase in the median alpha(1)-AT concentration (0.05 (0.03-0.08) nM v 0.03 (0.02-0.08) nM, p<0.01) in the DTT treated samples. DTT had no effect on the assay standards for IL-1beta, IL-8 or TNFalpha, but at higher concentrations it did affect IL-6, SLPI, NE, and LTB(4) standards (43%, 70%, 76% and 643% of control value for top standard, respectively) and at all concentrations DTT completely abolished MPO activity. CONCLUSIONS: Sputum processing with DTT significantly reduces the detectable concentration of TNFalpha, LTB(4) and MPO, and produces a small but significant increase in median alpha(1)-AT levels. To avoid this problem we recommend that an untreated aliquot of sputum be retained for cytokine analysis, unless the assay has been specifically validated.  (+info)

Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. (6/165)

BACKGROUND: A study was undertaken to evaluate Chlamydia pneumoniae chronic infection, other respiratory infections, and functional impairment in patients with chronic bronchitis (stage 1) and to examine chronic C pneumoniae infection, rate of acute exacerbations of chronic bronchitis, and rate of C pneumoniae eradication following antibiotic treatment (stage 2). METHODS: In the stage 1 study respiratory specimens from 42 patients with steady state chronic bronchitis were analysed for Gram staining, sputum culture, and C pneumoniae DNA detection by nested touchdown polymerase chain reaction (PCR). On the basis of the results of stage 1, a second population of 141 consecutive patients with steady state mild to moderate chronic bronchitis (FEV(1) >or=50% predicted) was studied. On admission, at regular intervals, and at exacerbation all patients underwent serological testing for C pneumoniae (microimmunofluorescence) and a nested touchdown PCR to detect C pneumoniae DNA was performed on peripheral blood mononuclear cells (PBMCs). Patients were assessed over a 12 month period. Information regarding the previous 12 months was taken from medical records. RESULTS: Chronic colonisation of the sputum with C pneumoniae was significantly associated with lower FEV(1) and greater airway bacterial colonisation. On admission to the stage 2 study, 80 patients were PCR negative and 61 were PCR positive. Over the 2 years a mean (SD) of 1.43 (1.32) acute exacerbations occurred in PCR negative patients and 2.03 (1.21) in PCR positive patients (p<0.01). During the 12 month follow up period 34 PCR positive patients had acute exacerbations and were treated with azithromycin for 6 weeks. Serological evidence of acute C pneumoniae reinfection/reactivation was found in two of the 34 patients. The rate of C pneumoniae DNA clearance from blood following treatment was 29% at follow up. CONCLUSION: Chronic colonisation with C pneumoniae is associated with a higher rate of exacerbations of chronic bronchitis. Long term treatment is required to obtain clearance of the organism from the blood.  (+info)

Chronic obstructive pulmonary disease. 4: imaging the lungs in patients with chronic obstructive pulmonary disease. (7/165)

The role of chest radiography and computed tomography in the evaluation of pulmonary emphysema and chronic bronchitis is reviewed.  (+info)

Chronic bronchitis among French adults: high prevalence and underdiagnosis. (8/165)

The aims of this survey were to determine the prevalence of symptoms indicative of chronic bronchitis (CB) in the French adult population, to identify the role of risk factors for CB, and to assess rates of CB diagnosis and pulmonary function testing (PFT) in the presence of CB. A representative sample of 14,076 individuals aged > or = 25 yrs completed a self-administered questionnaire on symptoms, comorbidities, smoking history, sociodemographical data, and diagnosis and care by physicians. The prevalence of CB was 4.1% and the prevalence of chronic cough and/or expectoration was 11.7%. In individuals with comorbidity, these figures were 10.4% and 24.4%, respectively. Smoking was associated with an increased frequency of CB. In subjects with CB, 44.6% had PFT (spirometry or peak expiratory flow measurement), 24% were diagnosed as having CB, and 7.2% received care. Rates of diagnosis, PFT, and follow-up were lower in young individuals and in those without comorbidity. PFT and follow-up were less common in current smokers. Prevalence of chronic bronchitis in French adults is high and similar in magnitude to that of other industrialised countries. Comorbidities and tobacco smoking increase the frequency of chronic bronchitis symptoms. Chronic bronchitis is too infrequently diagnosed, investigated and cared for.  (+info)

Bronchitis is a medical condition characterized by inflammation of the bronchi, which are the large airways that lead to the lungs. This inflammation can cause a variety of symptoms, including coughing, wheezing, chest tightness, and shortness of breath. Bronchitis can be either acute or chronic.

Acute bronchitis is usually caused by a viral infection, such as a cold or the flu, and typically lasts for a few days to a week. Symptoms may include a productive cough (coughing up mucus or phlegm), chest discomfort, and fatigue. Acute bronchitis often resolves on its own without specific medical treatment, although rest, hydration, and over-the-counter medications to manage symptoms may be helpful.

Chronic bronchitis, on the other hand, is a long-term condition that is characterized by a persistent cough with mucus production that lasts for at least three months out of the year for two consecutive years. Chronic bronchitis is typically caused by exposure to irritants such as cigarette smoke, air pollution, or occupational dusts and chemicals. It is often associated with chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis and emphysema.

Treatment for chronic bronchitis may include medications to help open the airways, such as bronchodilators and corticosteroids, as well as lifestyle changes such as smoking cessation and avoiding irritants. In severe cases, oxygen therapy or lung transplantation may be necessary.

Chronic bronchitis is a long-term inflammation of the airways (bronchi) in the lungs. It is characterized by a persistent cough that produces excessive mucus or sputum. The cough and mucus production must be present for at least three months in two consecutive years to meet the diagnostic criteria for chronic bronchitis.

The inflammation of the airways can lead to narrowing, obstructing the flow of air into and out of the lungs, resulting in shortness of breath and wheezing. Chronic bronchitis is often associated with exposure to irritants such as tobacco smoke, dust, or chemical fumes over an extended period.

It is a significant component of chronic obstructive pulmonary disease (COPD), which also includes emphysema. While there is no cure for chronic bronchitis, treatments can help alleviate symptoms and slow the progression of the disease. These may include bronchodilators, corticosteroids, and pulmonary rehabilitation. Quitting smoking is crucial in managing this condition.

Infectious Bronchitis Virus (IBV) is a single-stranded, enveloped RNA virus belonging to the genus Gammacoronavirus and family Coronaviridae. It is the causative agent of infectious bronchitis (IB), a highly contagious respiratory disease in birds, particularly in chickens. The virus primarily affects the upper respiratory tract, causing tracheitis, bronchitis, and sinusitis. In addition to respiratory issues, IBV can also lead to decreased egg production, poor growth rates, and impaired immune response in infected birds. Several serotypes and variants of IBV exist worldwide, making vaccine development and disease control challenging.

Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. They are named for the crown-like (corona) appearance of their surface proteins. Coronaviruses infect a wide range of animals, including mammals and birds, and can cause respiratory, gastrointestinal, and neurological diseases. Some coronaviruses, such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV), can cause severe and potentially fatal illness in humans. The most recent example is SARS-CoV-2, which causes COVID-19.

Coronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases such as pneumonia. The name "coronavirus" comes from the Latin word "corona," which means crown or halo, reflecting the distinctive appearance of the virus particles under electron microscopy, which have a crown-like structure due to the presence of spike proteins on their surface.

Coronaviruses are zoonotic, meaning they can be transmitted between animals and humans. Some coronaviruses are endemic in certain animal populations and occasionally jump to humans, causing outbreaks of new diseases. This is what happened with Severe Acute Respiratory Syndrome (SARS) in 2002-2003, Middle East Respiratory Syndrome (MERS) in 2012, and the most recent Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2.

Coronavirus infections typically cause respiratory symptoms such as cough, shortness of breath, and fever. In severe cases, they can lead to pneumonia, acute respiratory distress syndrome (ARDS), and even death, especially in older adults or people with underlying medical conditions. Other symptoms may include fatigue, muscle aches, headache, sore throat, and gastrointestinal issues such as nausea, vomiting, and diarrhea.

Preventive measures for coronavirus infections include frequent hand washing, wearing face masks, practicing social distancing, avoiding close contact with sick individuals, and covering the mouth and nose when coughing or sneezing. There are currently vaccines available to prevent COVID-19, which have been shown to be highly effective in preventing severe illness, hospitalization, and death from the disease.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

A cough is a reflex action that helps to clear the airways of irritants, foreign particles, or excess mucus or phlegm. It is characterized by a sudden, forceful expulsion of air from the lungs through the mouth and nose. A cough can be acute (short-term) or chronic (long-term), and it can be accompanied by other symptoms such as chest pain, shortness of breath, or fever. Coughing can be caused by various factors, including respiratory infections, allergies, asthma, environmental pollutants, gastroesophageal reflux disease (GERD), and chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and bronchitis. In some cases, a cough may be a symptom of a more serious underlying condition, such as heart failure or lung cancer.

Respiratory tract diseases refer to a broad range of medical conditions that affect the respiratory system, which includes the nose, throat (pharynx), windpipe (trachea), bronchi, bronchioles, and lungs. These diseases can be categorized into upper and lower respiratory tract infections based on the location of the infection.

Upper respiratory tract infections affect the nose, sinuses, pharynx, and larynx, and include conditions such as the common cold, flu, sinusitis, and laryngitis. Symptoms often include nasal congestion, sore throat, cough, and fever.

Lower respiratory tract infections affect the trachea, bronchi, bronchioles, and lungs, and can be more severe. They include conditions such as pneumonia, bronchitis, and tuberculosis. Symptoms may include cough, chest congestion, shortness of breath, and fever.

Respiratory tract diseases can also be caused by allergies, irritants, or genetic factors. Treatment varies depending on the specific condition and severity but may include medications, breathing treatments, or surgery in severe cases.

Sputum is defined as a mixture of saliva and phlegm that is expelled from the respiratory tract during coughing, sneezing or deep breathing. It can be clear, mucoid, or purulent (containing pus) depending on the underlying cause of the respiratory issue. Examination of sputum can help diagnose various respiratory conditions such as infections, inflammation, or other lung diseases.

Poultry diseases refer to a wide range of infectious and non-infectious disorders that affect domesticated birds, particularly those raised for meat, egg, or feather production. These diseases can be caused by various factors including viruses, bacteria, fungi, parasites, genetic predisposition, environmental conditions, and management practices.

Infectious poultry diseases are often highly contagious and can lead to significant economic losses in the poultry industry due to decreased production, increased mortality, and reduced quality of products. Some examples of infectious poultry diseases include avian influenza, Newcastle disease, salmonellosis, colibacillosis, mycoplasmosis, aspergillosis, and coccidiosis.

Non-infectious poultry diseases can be caused by factors such as poor nutrition, environmental stressors, and management issues. Examples of non-infectious poultry diseases include ascites, fatty liver syndrome, sudden death syndrome, and various nutritional deficiencies.

Prevention and control of poultry diseases typically involve a combination of biosecurity measures, vaccination programs, proper nutrition, good management practices, and monitoring for early detection and intervention. Rapid and accurate diagnosis of poultry diseases is crucial to implementing effective treatment and prevention strategies, and can help minimize the impact of disease outbreaks on both individual flocks and the broader poultry industry.

Expectorants are a type of medication that help to thin and loosen mucus in the airways, making it easier to cough up and clear the airways. They work by increasing the production of fluid in the respiratory tract, which helps to moisten and soften thick or sticky mucus. This makes it easier for the cilia (tiny hair-like structures that line the airways) to move the mucus out of the lungs and into the throat, where it can be swallowed or spit out.

Expectorants are often used to treat respiratory conditions such as bronchitis, pneumonia, and chronic obstructive pulmonary disease (COPD), which can cause excessive mucus production and difficulty breathing. Some common expectorants include guaifenesin, iodinated glycerol, and potassium iodide.

It is important to follow the dosage instructions carefully when taking expectorants, as taking too much can lead to side effects such as nausea, vomiting, and diarrhea. It is also important to drink plenty of fluids while taking expectorants, as this can help to thin the mucus and make it easier to cough up.

Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, shortness of breath, and chest tightness. The airway obstruction in asthma is usually reversible, either spontaneously or with treatment.

The underlying cause of asthma involves a combination of genetic and environmental factors that result in hypersensitivity of the airways to certain triggers, such as allergens, irritants, viruses, exercise, and emotional stress. When these triggers are encountered, the airways constrict due to smooth muscle spasm, swell due to inflammation, and produce excess mucus, leading to the characteristic symptoms of asthma.

Asthma is typically managed with a combination of medications that include bronchodilators to relax the airway muscles, corticosteroids to reduce inflammation, and leukotriene modifiers or mast cell stabilizers to prevent allergic reactions. Avoiding triggers and monitoring symptoms are also important components of asthma management.

There are several types of asthma, including allergic asthma, non-allergic asthma, exercise-induced asthma, occupational asthma, and nocturnal asthma, each with its own set of triggers and treatment approaches. Proper diagnosis and management of asthma can help prevent exacerbations, improve quality of life, and reduce the risk of long-term complications.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

Pulmonary emphysema is a chronic respiratory disease characterized by abnormal, permanent enlargement of the airspaces distal to the terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis. This results in loss of elastic recoil, which leads to trappling of air within the lungs and difficulty exhaling. It is often caused by cigarette smoking or long-term exposure to harmful pollutants. The disease is part of a group of conditions known as chronic obstructive pulmonary disease (COPD), which also includes chronic bronchitis.

Obstructive lung disease is a category of respiratory diseases characterized by airflow limitation that causes difficulty in completely emptying the alveoli (tiny air sacs) of the lungs during exhaling. This results in the trapping of stale air and prevents fresh air from entering the alveoli, leading to various symptoms such as coughing, wheezing, shortness of breath, and decreased exercise tolerance.

The most common obstructive lung diseases include:

1. Chronic Obstructive Pulmonary Disease (COPD): A progressive disease that includes chronic bronchitis and emphysema, often caused by smoking or exposure to harmful pollutants.
2. Asthma: A chronic inflammatory disorder of the airways characterized by variable airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation. Symptoms can be triggered by various factors such as allergens, irritants, or physical activity.
3. Bronchiectasis: A condition in which the airways become abnormally widened, scarred, and thickened due to chronic inflammation or infection, leading to mucus buildup and impaired clearance.
4. Cystic Fibrosis: An inherited genetic disorder that affects the exocrine glands, resulting in thick and sticky mucus production in various organs, including the lungs. This can lead to chronic lung infections, inflammation, and airway obstruction.
5. Alpha-1 Antitrypsin Deficiency: A genetic condition characterized by low levels of alpha-1 antitrypsin protein, which leads to uncontrolled protease enzyme activity that damages the lung tissue, causing emphysema-like symptoms.

Treatment for obstructive lung diseases typically involves bronchodilators (to relax and widen the airways), corticosteroids (to reduce inflammation), and lifestyle modifications such as smoking cessation and pulmonary rehabilitation programs. In severe cases, oxygen therapy or even lung transplantation may be considered.

Emphysema is a chronic respiratory disease characterized by abnormal, permanent enlargement of the airspaces called alveoli in the lungs, accompanied by destruction of their walls. This results in loss of elasticity and decreased gas exchange efficiency, causing shortness of breath and coughing. It is often caused by smoking or exposure to harmful pollutants. The damage to the lungs is irreversible, but quitting smoking and using medications can help alleviate symptoms and slow disease progression.

Smoking is not a medical condition, but it's a significant health risk behavior. Here is the definition from a public health perspective:

Smoking is the act of inhaling and exhaling the smoke of burning tobacco that is commonly consumed through cigarettes, pipes, and cigars. The smoke contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, and numerous toxic and carcinogenic substances. These toxins contribute to a wide range of diseases and health conditions, such as lung cancer, heart disease, stroke, chronic obstructive pulmonary disease (COPD), and various other cancers, as well as adverse reproductive outcomes and negative impacts on the developing fetus during pregnancy. Smoking is highly addictive due to the nicotine content, which makes quitting smoking a significant challenge for many individuals.

Pulmonary heart disease, also known as cor pulmonale, is a type of heart disease that occurs as a complication of chronic lung diseases or hypoxia (low oxygen levels in the body). The condition is characterized by enlargement and thickening of the right ventricle of the heart, which results from increased pressure in the pulmonary artery due to damaged or narrowed blood vessels in the lungs. This can lead to symptoms such as shortness of breath, fatigue, swelling in the legs and abdomen, and irregular heart rhythms. The condition can be managed with medications, oxygen therapy, and lifestyle changes, but if left untreated, it can lead to serious complications such as heart failure.

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by the persistent obstruction of airflow in and out of the lungs. This obstruction is usually caused by two primary conditions: chronic bronchitis and emphysema. Chronic bronchitis involves inflammation and narrowing of the airways, leading to excessive mucus production and coughing. Emphysema is a condition where the alveoli (air sacs) in the lungs are damaged, resulting in decreased gas exchange and shortness of breath.

The main symptoms of COPD include progressive shortness of breath, chronic cough, chest tightness, wheezing, and excessive mucus production. The disease is often associated with exposure to harmful particles or gases, such as cigarette smoke, air pollution, or occupational dusts and chemicals. While there is no cure for COPD, treatments can help alleviate symptoms, improve quality of life, and slow the progression of the disease. These treatments may include bronchodilators, corticosteroids, combination inhalers, pulmonary rehabilitation, and, in severe cases, oxygen therapy or lung transplantation.

Respiratory Function Tests (RFTs) are a group of medical tests that measure how well your lungs take in and exhale air, and how well they transfer oxygen and carbon dioxide into and out of your blood. They can help diagnose certain lung disorders, measure the severity of lung disease, and monitor response to treatment.

RFTs include several types of tests, such as:

1. Spirometry: This test measures how much air you can exhale and how quickly you can do it. It's often used to diagnose and monitor conditions like asthma, chronic obstructive pulmonary disease (COPD), and other lung diseases.
2. Lung volume testing: This test measures the total amount of air in your lungs. It can help diagnose restrictive lung diseases, such as pulmonary fibrosis or sarcoidosis.
3. Diffusion capacity testing: This test measures how well oxygen moves from your lungs into your bloodstream. It's often used to diagnose and monitor conditions like pulmonary fibrosis, interstitial lung disease, and other lung diseases that affect the ability of the lungs to transfer oxygen to the blood.
4. Bronchoprovocation testing: This test involves inhaling a substance that can cause your airways to narrow, such as methacholine or histamine. It's often used to diagnose and monitor asthma.
5. Exercise stress testing: This test measures how well your lungs and heart work together during exercise. It's often used to diagnose lung or heart disease.

Overall, Respiratory Function Tests are an important tool for diagnosing and managing a wide range of lung conditions.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Forced Expiratory Volume (FEV) is a medical term used to describe the volume of air that can be forcefully exhaled from the lungs in one second. It is often measured during pulmonary function testing to assess lung function and diagnose conditions such as chronic obstructive pulmonary disease (COPD) or asthma.

FEV is typically expressed as a percentage of the Forced Vital Capacity (FVC), which is the total volume of air that can be exhaled from the lungs after taking a deep breath in. The ratio of FEV to FVC is used to determine whether there is obstruction in the airways, with a lower ratio indicating more severe obstruction.

There are different types of FEV measurements, including FEV1 (the volume of air exhaled in one second), FEV25-75 (the average volume of air exhaled during the middle 50% of the FVC maneuver), and FEV0.5 (the volume of air exhaled in half a second). These measurements can provide additional information about lung function and help guide treatment decisions.

Nasopharyngitis is the medical term for inflammation of the nasopharynx, which is the upper part of the throat behind the nose. It is often caused by viral infections such as the common cold, but can also be due to bacterial or allergic causes. Symptoms may include a runny or stuffy nose, sore throat, sneezing, and cough.

Bronchiectasis is a medical condition characterized by permanent, abnormal widening and thickening of the walls of the bronchi (the airways leading to the lungs). This can lead to recurrent respiratory infections, coughing, and the production of large amounts of sputum. The damage to the airways is usually irreversible and can be caused by various factors such as bacterial or viral infections, genetic disorders, immune deficiencies, or exposure to environmental pollutants. In some cases, the cause may remain unknown. Treatment typically includes chest physiotherapy, bronchodilators, antibiotics, and sometimes surgery.

Spirometry is a common type of pulmonary function test (PFT) that measures how well your lungs work. This is done by measuring how much air you can exhale from your lungs after taking a deep breath, and how quickly you can exhale it. The results are compared to normal values for your age, height, sex, and ethnicity.

Spirometry is used to diagnose and monitor certain lung conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases that cause narrowing of the airways. It can also be used to assess the effectiveness of treatment for these conditions. The test is non-invasive, safe, and easy to perform.

Coronaviridae is a family of enveloped, positive-sense RNA viruses that cause various diseases in animals and humans. Human coronavirus infections most commonly result in mild to moderate upper respiratory tract illnesses, such as the common cold. However, two highly pathogenic coronaviruses have emerged in the past two decades: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). These viruses can cause severe and potentially fatal respiratory illnesses.

In general, coronaviruses are transmitted through respiratory droplets produced when an infected person coughs, sneezes, or talks. In some cases, people may become infected by touching a surface contaminated with the virus and then touching their mouth, nose, or eyes. Preventive measures include frequent handwashing, avoiding close contact with sick individuals, and practicing good respiratory etiquette (e.g., covering coughs and sneezes).

Treatment for coronavirus infections is primarily supportive, focusing on relieving symptoms and managing complications. For severe cases of SARS-CoV and MERS-CoV infections, antiviral medications and supportive care in an intensive care unit may be necessary. Vaccines have been developed to protect against SARS-CoV-2, the virus that causes COVID-19, and are being distributed globally.

Vital capacity (VC) is a term used in pulmonary function tests to describe the maximum volume of air that can be exhaled after taking a deep breath. It is the sum of inspiratory reserve volume, tidal volume, and expiratory reserve volume. In other words, it's the total amount of air you can forcibly exhale after inhaling as deeply as possible. Vital capacity is an important measurement in assessing lung function and can be reduced in conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders.

Respiratory sounds are the noises produced by the airflow through the respiratory tract during breathing. These sounds can provide valuable information about the health and function of the lungs and airways. They are typically categorized into two main types: normal breath sounds and adventitious (or abnormal) breath sounds.

Normal breath sounds include:

1. Vesicular breath sounds: These are soft, low-pitched sounds heard over most of the lung fields during quiet breathing. They are produced by the movement of air through the alveoli and smaller bronchioles.
2. Bronchovesicular breath sounds: These are medium-pitched, hollow sounds heard over the mainstem bronchi and near the upper sternal border during both inspiration and expiration. They are a combination of vesicular and bronchial breath sounds.

Abnormal or adventitious breath sounds include:

1. Crackles (or rales): These are discontinuous, non-musical sounds that resemble the crackling of paper or bubbling in a fluid-filled container. They can be heard during inspiration and are caused by the sudden opening of collapsed airways or the movement of fluid within the airways.
2. Wheezes: These are continuous, musical sounds resembling a whistle. They are produced by the narrowing or obstruction of the airways, causing turbulent airflow.
3. Rhonchi: These are low-pitched, rumbling, continuous sounds that can be heard during both inspiration and expiration. They are caused by the vibration of secretions or fluids in the larger airways.
4. Stridor: This is a high-pitched, inspiratory sound that resembles a harsh crowing or barking noise. It is usually indicative of upper airway narrowing or obstruction.

The character, location, and duration of respiratory sounds can help healthcare professionals diagnose various respiratory conditions, such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and bronchitis.

Airway obstruction is a medical condition that occurs when the normal flow of air into and out of the lungs is partially or completely blocked. This blockage can be caused by a variety of factors, including swelling of the tissues in the airway, the presence of foreign objects or substances, or abnormal growths such as tumors.

When the airway becomes obstructed, it can make it difficult for a person to breathe normally. They may experience symptoms such as shortness of breath, wheezing, coughing, and chest tightness. In severe cases, airway obstruction can lead to respiratory failure and other life-threatening complications.

There are several types of airway obstruction, including:

1. Upper airway obstruction: This occurs when the blockage is located in the upper part of the airway, such as the nose, throat, or voice box.
2. Lower airway obstruction: This occurs when the blockage is located in the lower part of the airway, such as the trachea or bronchi.
3. Partial airway obstruction: This occurs when the airway is partially blocked, allowing some air to flow in and out of the lungs.
4. Complete airway obstruction: This occurs when the airway is completely blocked, preventing any air from flowing into or out of the lungs.

Treatment for airway obstruction depends on the underlying cause of the condition. In some cases, removing the obstruction may be as simple as clearing the airway of foreign objects or mucus. In other cases, more invasive treatments such as surgery may be necessary.

"Bronchi" are a pair of airways in the respiratory system that branch off from the trachea (windpipe) and lead to the lungs. They are responsible for delivering oxygen-rich air to the lungs and removing carbon dioxide during exhalation. The right bronchus is slightly larger and more vertical than the left, and they further divide into smaller branches called bronchioles within the lungs. Any abnormalities or diseases affecting the bronchi can impact lung function and overall respiratory health.

Coal mining is the process of extracting coal from the ground. Coal is a fossil fuel that is formed from the accumulation and decomposition of plants over millions of years. It is primarily used as a source of energy for electricity generation, as well as for heating and industrial processes.

There are two main types of coal mining: surface mining and underground mining. Surface mining involves removing the soil and rock above the coal seam to access the coal, while underground mining involves sinking shafts and tunnels into the earth to reach the coal. Both methods have their own set of benefits and challenges, and the choice of which method to use depends on various factors such as the depth and location of the coal seam, the geology of the area, and environmental concerns.

Coal mining can be a dangerous occupation, with risks including accidents, explosions, and exposure to harmful dust and gases. As a result, it is essential that coal miners receive proper training and equipment to minimize these risks and ensure their safety. Additionally, coal mining has significant environmental impacts, including deforestation, habitat destruction, and water pollution, which must be carefully managed to minimize harm.

Fossil fuels are not a medical term, but rather a term used in the field of earth science and energy production. They refer to fuels formed by natural processes such as anaerobic decomposition of buried dead organisms. The age of the organisms and their resulting fossil fuels is typically millions of years, and sometimes even hundreds of millions of years.

There are three main types of fossil fuels: coal, petroleum, and natural gas. Coal is primarily composed of carbon and hydrogen, and it is formed from the remains of plants that lived hundreds of millions of years ago in swamps and peat bogs. Petroleum, also known as crude oil, is a liquid mixture of hydrocarbons and other organic compounds, formed from the remains of marine organisms such as algae and zooplankton. Natural gas is primarily composed of methane and other light hydrocarbons, and it is found in underground reservoirs, often in association with petroleum deposits.

Fossil fuels are a major source of energy for transportation, heating, and electricity generation, but their combustion also releases large amounts of carbon dioxide and other pollutants into the atmosphere, contributing to climate change and air pollution.

In medical terms, "dust" is not defined as a specific medical condition or disease. However, generally speaking, dust refers to small particles of solid matter that can be found in the air and can come from various sources, such as soil, pollen, hair, textiles, paper, or plastic.

Exposure to certain types of dust, such as those containing allergens, chemicals, or harmful pathogens, can cause a range of health problems, including respiratory issues like asthma, allergies, and lung diseases. Prolonged exposure to certain types of dust, such as silica or asbestos, can even lead to serious conditions like silicosis or mesothelioma.

Therefore, it is important for individuals who work in environments with high levels of dust to take appropriate precautions, such as wearing masks and respirators, to minimize their exposure and reduce the risk of health problems.

Respiratory disorders are a group of conditions that affect the respiratory system, including the nose, throat (pharynx), windpipe (trachea), bronchi, lungs, and diaphragm. These disorders can make it difficult for a person to breathe normally and may cause symptoms such as coughing, wheezing, shortness of breath, and chest pain.

There are many different types of respiratory disorders, including:

1. Asthma: A chronic inflammatory disease that causes the airways to become narrow and swollen, leading to difficulty breathing.
2. Chronic obstructive pulmonary disease (COPD): A group of lung diseases, including emphysema and chronic bronchitis, that make it hard to breathe.
3. Pneumonia: An infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
4. Lung cancer: A type of cancer that forms in the tissues of the lungs and can cause symptoms such as coughing, chest pain, and shortness of breath.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Sleep apnea: A disorder that causes a person to stop breathing for short periods during sleep.
7. Interstitial lung disease: A group of disorders that cause scarring of the lung tissue, leading to difficulty breathing.
8. Pulmonary fibrosis: A type of interstitial lung disease that causes scarring of the lung tissue and makes it hard to breathe.
9. Pleural effusion: An abnormal accumulation of fluid in the space between the lungs and chest wall.
10. Lung transplantation: A surgical procedure to replace a diseased or failing lung with a healthy one from a donor.

Respiratory disorders can be caused by a variety of factors, including genetics, exposure to environmental pollutants, smoking, and infections. Treatment for respiratory disorders may include medications, oxygen therapy, breathing exercises, and lifestyle changes. In some cases, surgery may be necessary to treat the disorder.

"Chickens" is a common term used to refer to the domesticated bird, Gallus gallus domesticus, which is widely raised for its eggs and meat. However, in medical terms, "chickens" is not a standard term with a specific definition. If you have any specific medical concern or question related to chickens, such as food safety or allergies, please provide more details so I can give a more accurate answer.

I'm sorry for any confusion, but "Textile Industry" and "medical definition" are not related. The textile industry is the overall system of designing, producing, and distributing clothing and their raw materials, which include fiber, yarn, and cloth. It involves several processes such as spinning, weaving, knitting, dyeing, and finishing.

If you're looking for a medical term or definition, please provide me with the term so I can assist you better.

Bronchoscopy is a medical procedure that involves the examination of the inside of the airways and lungs with a flexible or rigid tube called a bronchoscope. This procedure allows healthcare professionals to directly visualize the airways, take tissue samples for biopsy, and remove foreign objects or secretions. Bronchoscopy can be used to diagnose and manage various respiratory conditions such as lung infections, inflammation, cancer, and bleeding. It is usually performed under local or general anesthesia to minimize discomfort and risks associated with the procedure.

Occupational diseases are health conditions or illnesses that occur as a result of exposure to hazards in the workplace. These hazards can include physical, chemical, and biological agents, as well as ergonomic factors and work-related psychosocial stressors. Examples of occupational diseases include respiratory illnesses caused by inhaling dust or fumes, hearing loss due to excessive noise exposure, and musculoskeletal disorders caused by repetitive movements or poor ergonomics. The development of an occupational disease is typically related to the nature of the work being performed and the conditions in which it is carried out. It's important to note that these diseases can be prevented or minimized through proper risk assessment, implementation of control measures, and adherence to safety regulations.

Lung diseases refer to a broad category of disorders that affect the lungs and other structures within the respiratory system. These diseases can impair lung function, leading to symptoms such as coughing, shortness of breath, chest pain, and wheezing. They can be categorized into several types based on the underlying cause and nature of the disease process. Some common examples include:

1. Obstructive lung diseases: These are characterized by narrowing or blockage of the airways, making it difficult to breathe out. Examples include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and cystic fibrosis.
2. Restrictive lung diseases: These involve stiffening or scarring of the lungs, which reduces their ability to expand and take in air. Examples include idiopathic pulmonary fibrosis, sarcoidosis, and asbestosis.
3. Infectious lung diseases: These are caused by bacteria, viruses, fungi, or parasites that infect the lungs. Examples include pneumonia, tuberculosis, and influenza.
4. Vascular lung diseases: These affect the blood vessels in the lungs, impairing oxygen exchange. Examples include pulmonary embolism, pulmonary hypertension, and chronic thromboembolic pulmonary hypertension (CTEPH).
5. Neoplastic lung diseases: These involve abnormal growth of cells within the lungs, leading to cancer. Examples include small cell lung cancer, non-small cell lung cancer, and mesothelioma.
6. Other lung diseases: These include interstitial lung diseases, pleural effusions, and rare disorders such as pulmonary alveolar proteinosis and lymphangioleiomyomatosis (LAM).

It is important to note that this list is not exhaustive, and there are many other conditions that can affect the lungs. Proper diagnosis and treatment of lung diseases require consultation with a healthcare professional, such as a pulmonologist or respiratory therapist.

Pneumoconiosis is a group of lung diseases caused by inhaling dust particles, leading to fibrosis or scarring of the lungs. The type of pneumoconiosis depends on the specific dust inhaled. Examples include coal worker's pneumoconiosis (from coal dust), silicosis (from crystalline silica dust), and asbestosis (from asbestos fibers). These diseases are generally preventable by minimizing exposure to harmful dusts through proper engineering controls, protective equipment, and workplace safety regulations.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

Cefuroxime is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are unable to grow and multiply, and are eventually destroyed by the body's immune system.

Cefuroxime is effective against many different types of bacteria, including both Gram-positive and Gram-negative organisms. It is often used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections.

Like all antibiotics, cefuroxime should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which are more difficult to treat and can pose a serious threat to public health.

Tachypnea is a medical term that refers to an abnormally increased respiratory rate, which is typically defined as more than 20-24 breaths per minute in adults and more than 60 breaths per minute in infants. It can occur due to various physiological or pathological conditions such as hypoxia, anxiety, fever, heart failure, lung diseases, or other systemic illnesses. Tachypnea should be differentiated from hyperventilation, which is characterized by an increased rate and depth of respiration leading to hypocapnia (low carbon dioxide levels in the blood).

Byssinosis is a respiratory condition that primarily affects textile workers who are exposed to high levels of cotton, flax, or hemp dust. It's also known as brown lung disease. The medical definition of byssinosis is:

A restrictive lung disease characterized by chest tightness, cough, and shortness of breath that typically occurs in workers exposed to high levels of organic dust from cotton, flax, or hemp. The symptoms usually appear after the first day of exposure (known as "Monday fever") and improve with continued exposure during the week, only to recur again at the beginning of the next workweek. Chronic byssinosis can lead to progressive shortness of breath, chronic cough, and significant lung function impairment. The exact mechanism by which the dust causes the disease is not fully understood but may involve an immune response or direct toxicity to the airways.

Ipratropium is an anticholinergic bronchodilator medication that is often used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It works by blocking the action of acetylcholine, a chemical messenger in the body that causes muscles around the airways to tighten and narrow. By preventing this effect, ipratropium helps to relax the muscles around the airways, making it easier to breathe.

Ipratropium is available in several forms, including an aerosol spray, nebulizer solution, and dry powder inhaler. It is typically used in combination with other respiratory medications, such as beta-agonists or corticosteroids, to provide more effective relief of symptoms. Common side effects of ipratropium include dry mouth, throat irritation, and headache.

Mucociliary clearance is a vital defense mechanism of the respiratory system that involves the coordinated movement of tiny hair-like structures called cilia, which are present on the surface of the respiratory epithelium, and the mucus layer. This mechanism helps to trap inhaled particles, microorganisms, and other harmful substances and move them away from the lungs towards the upper airways, where they can be swallowed or coughed out.

The cilia beat in a coordinated manner, moving in a wave-like motion to propel the mucus layer upwards. This continuous movement helps to clear the airways of any debris and maintain a clean and healthy respiratory system. Mucociliary clearance plays an essential role in preventing respiratory infections and maintaining lung function. Any impairment in this mechanism, such as due to smoking or certain respiratory conditions, can increase the risk of respiratory infections and other related health issues.

Atropine derivatives are a class of drugs that are chemically related to atropine, an alkaloid found in the nightshade family of plants. These drugs have anticholinergic properties, which means they block the action of the neurotransmitter acetylcholine in the body.

Atropine derivatives can be used for a variety of medical purposes, including:

1. Treating motion sickness and vertigo
2. Dilating the pupils during eye examinations
3. Reducing saliva production during surgical procedures
4. Treating certain types of poisoning, such as organophosphate or nerve gas poisoning
5. Managing symptoms of some neurological disorders, such as Parkinson's disease and myasthenia gravis

Some examples of atropine derivatives include hyoscyamine, scopolamine, and ipratropium. These drugs can have side effects, including dry mouth, blurred vision, constipation, difficulty urinating, and rapid heartbeat. They should be used with caution and under the supervision of a healthcare provider.

Mucus is a viscous, slippery secretion produced by the mucous membranes that line various body cavities such as the respiratory and gastrointestinal tracts. It serves to lubricate and protect these surfaces from damage, infection, and foreign particles. Mucus contains water, proteins, salts, and other substances, including antibodies, enzymes, and glycoproteins called mucins that give it its characteristic gel-like consistency.

In the respiratory system, mucus traps inhaled particles such as dust, allergens, and pathogens, preventing them from reaching the lungs. The cilia, tiny hair-like structures lining the airways, move the mucus upward toward the throat, where it can be swallowed or expelled through coughing or sneezing. In the gastrointestinal tract, mucus helps protect the lining of the stomach and intestines from digestive enzymes and other harmful substances.

Excessive production of mucus can occur in various medical conditions such as allergies, respiratory infections, chronic lung diseases, and gastrointestinal disorders, leading to symptoms such as coughing, wheezing, nasal congestion, and diarrhea.

I must apologize, but "welding" is not a term that is typically used in medical definitions. Welding is a process that is commonly used in manufacturing and construction to join two pieces of metal together by melting them and adding a filler material to form a pool of molten metal (the weld puddle) that cools to become a strong joint.

If you have any questions related to medical terminology or health-related topics, I would be happy to help answer them for you.

Bronchiolitis is a common respiratory infection in infants and young children, typically caused by a viral infection. It is characterized by inflammation and congestion of the bronchioles (the smallest airways in the lungs), which can lead to difficulty breathing and wheezing.

The most common virus that causes bronchiolitis is respiratory syncytial virus (RSV), but other viruses such as rhinovirus, influenza, and parainfluenza can also cause the condition. Symptoms of bronchiolitis may include cough, wheezing, rapid breathing, difficulty feeding, and fatigue.

In severe cases, bronchiolitis can lead to respiratory distress and require hospitalization. Treatment typically involves supportive care, such as providing fluids and oxygen therapy, and in some cases, medications to help open the airways may be used. Prevention measures include good hand hygiene and avoiding close contact with individuals who are sick.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Eosinophilia is a medical condition characterized by an abnormally high concentration of eosinophils in the circulating blood. Eosinophils are a type of white blood cell that play an important role in the immune system, particularly in fighting off parasitic infections and regulating allergic reactions. However, when their numbers become excessively high, they can contribute to tissue damage and inflammation.

Eosinophilia is typically defined as a count of more than 500 eosinophils per microliter of blood. Mild eosinophilia (up to 1,500 cells/μL) may not cause any symptoms and may be discovered during routine blood tests. However, higher levels of eosinophilia can lead to various symptoms such as coughing, wheezing, skin rashes, and organ damage, depending on the underlying cause.

The causes of eosinophilia are varied and can include allergic reactions, parasitic infections, autoimmune disorders, certain medications, and some types of cancer. Accurate diagnosis and treatment of eosinophilia require identification and management of the underlying cause.

Tracheitis is a medical condition that involves inflammation of the trachea, or windpipe. It can cause symptoms such as cough, sore throat, difficulty swallowing, and fever. Tracheitis can be caused by viral or bacterial infections, and it may also occur as a complication of other respiratory conditions. In some cases, tracheitis may require medical treatment, including antibiotics for bacterial infections or corticosteroids to reduce inflammation. It is important to seek medical attention if you experience symptoms of tracheitis, especially if they are severe or persistent.

Occupational exposure refers to the contact of an individual with potentially harmful chemical, physical, or biological agents as a result of their job or occupation. This can include exposure to hazardous substances such as chemicals, heavy metals, or dusts; physical agents such as noise, radiation, or ergonomic stressors; and biological agents such as viruses, bacteria, or fungi.

Occupational exposure can occur through various routes, including inhalation, skin contact, ingestion, or injection. Prolonged or repeated exposure to these hazards can increase the risk of developing acute or chronic health conditions, such as respiratory diseases, skin disorders, neurological damage, or cancer.

Employers have a legal and ethical responsibility to minimize occupational exposures through the implementation of appropriate control measures, including engineering controls, administrative controls, personal protective equipment, and training programs. Regular monitoring and surveillance of workers' health can also help identify and prevent potential health hazards in the workplace.

A "mass chest X-ray" is a term used to describe a radiological screening procedure where a large number of individuals undergo chest X-rays, usually as part of a public health campaign or community screening event. The goal is to identify any early signs of lung diseases such as tuberculosis, lung cancer, or other pulmonary abnormalities. It's important to note that while mass screenings can help detect diseases at an earlier stage, they also raise concerns about radiation exposure and the potential for overdiagnosis. Therefore, such procedures are typically carried out under strict medical guidelines and regulations.

Pneumonia is an infection or inflammation of the alveoli (tiny air sacs) in one or both lungs. It's often caused by bacteria, viruses, or fungi. Accumulated pus and fluid in these air sacs make it difficult to breathe, which can lead to coughing, chest pain, fever, and difficulty breathing. The severity of symptoms can vary from mild to life-threatening, depending on the underlying cause, the patient's overall health, and age. Pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment usually involves antibiotics for bacterial pneumonia, antivirals for viral pneumonia, and supportive care like oxygen therapy, hydration, and rest.

Haemophilus influenzae is a gram-negative, coccobacillary bacterium that can cause a variety of infectious diseases in humans. It is part of the normal respiratory flora but can become pathogenic under certain circumstances. The bacteria are named after their initial discovery in 1892 by Richard Pfeiffer during an influenza pandemic, although they are not the causative agent of influenza.

There are six main serotypes (a-f) based on the polysaccharide capsule surrounding the bacterium, with type b (Hib) being the most virulent and invasive. Hib can cause severe invasive diseases such as meningitis, pneumonia, epiglottitis, and sepsis, particularly in children under 5 years of age. The introduction of the Hib conjugate vaccine has significantly reduced the incidence of these invasive diseases.

Non-typeable Haemophilus influenzae (NTHi) strains lack a capsule and are responsible for non-invasive respiratory tract infections, such as otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease (COPD). NTHi can also cause invasive diseases but at lower frequency compared to Hib.

Proper diagnosis and antibiotic susceptibility testing are crucial for effective treatment, as Haemophilus influenzae strains may display resistance to certain antibiotics.

Forced expiratory flow rates (FEFR) are measures of how quickly and efficiently air can be exhaled from the lungs during a forced breath maneuver. These measurements are often used in pulmonary function testing to help diagnose and monitor obstructive lung diseases such as asthma or chronic obstructive pulmonary disease (COPD).

FEFR is typically measured during a forced expiratory maneuver, where the person takes a deep breath in and then exhales as forcefully and quickly as possible into a mouthpiece connected to a spirometer. The spirometer measures the volume and flow rate of the exhaled air over time.

There are several different FEFR measurements that can be reported, including:

* Forced Expiratory Flow (FEF) 25-75%: This is the average flow rate during the middle half of the forced expiratory maneuver.
* Peak Expiratory Flow Rate (PEFR): This is the maximum flow rate achieved during the first second of the forced expiratory maneuver.
* Forced Expiratory Volume in 1 Second (FEV1): This is the volume of air exhaled in the first second of the forced expiratory maneuver.

Abnormal FEFR values can indicate obstruction in the small airways of the lungs, which can make it difficult to breathe out fully and quickly. The specific pattern of abnormalities in FEFR measurements can help doctors differentiate between different types of obstructive lung diseases.

"Agricultural Workers' Diseases" is a term used to describe a variety of health conditions and illnesses that are associated with agricultural work. These can include both acute and chronic conditions, and can be caused by a range of factors including exposure to chemicals, dusts, allergens, physical injuries, and biological agents such as bacteria and viruses.

Some common examples of Agricultural Workers' Diseases include:

1. Pesticide poisoning: This can occur when agricultural workers are exposed to high levels of pesticides or other chemicals used in farming. Symptoms can range from mild skin irritation to severe neurological damage, depending on the type and amount of chemical exposure.
2. Respiratory diseases: Agricultural workers can be exposed to a variety of dusts and allergens that can cause respiratory problems such as asthma, bronchitis, and farmer's lung. These conditions are often caused by prolonged exposure to moldy hay, grain dust, or other organic materials.
3. Musculoskeletal injuries: Agricultural workers are at risk of developing musculoskeletal injuries due to the physical demands of their job. This can include back pain, repetitive strain injuries, and sprains and strains from lifting heavy objects.
4. Zoonotic diseases: Agricultural workers who come into contact with animals are at risk of contracting zoonotic diseases, which are illnesses that can be transmitted between animals and humans. Examples include Q fever, brucellosis, and leptospirosis.
5. Heat-related illnesses: Agricultural workers who work outside in hot weather are at risk of heat-related illnesses such as heat exhaustion and heat stroke.

Prevention of Agricultural Workers' Diseases involves a combination of engineering controls, personal protective equipment, and training to help workers understand the risks associated with their job and how to minimize exposure to hazards.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Diagnostic techniques for the respiratory system are methods used to identify and diagnose various diseases and conditions affecting the lungs and breathing. Here are some commonly used diagnostic techniques:

1. Physical Examination: A healthcare provider will listen to your chest with a stethoscope to check for abnormal breath sounds, such as wheezing or crackles. They may also observe your respiratory rate and effort.
2. Chest X-ray: This imaging test can help identify abnormalities in the lungs, such as tumors, fluid accumulation, or collapsed lung sections.
3. Computed Tomography (CT) Scan: A CT scan uses X-rays to create detailed cross-sectional images of the lungs and surrounding structures. It can help detect nodules, cysts, or other abnormalities that may not be visible on a chest X-ray.
4. Pulmonary Function Tests (PFTs): These tests measure how well your lungs are working by assessing your ability to inhale and exhale air. Common PFTs include spirometry, lung volume measurement, and diffusing capacity testing.
5. Bronchoscopy: A thin, flexible tube with a camera and light is inserted through the nose or mouth into the airways to examine the lungs' interior and obtain tissue samples for biopsy.
6. Bronchoalveolar Lavage (BAL): During a bronchoscopy, fluid is introduced into a specific area of the lung and then suctioned out to collect cells and other materials for analysis.
7. Sleep Studies: These tests monitor your breathing patterns during sleep to diagnose conditions like sleep apnea or other sleep-related breathing disorders.
8. Sputum Analysis: A sample of coughed-up mucus is examined under a microscope to identify any abnormal cells, bacteria, or other organisms that may be causing respiratory issues.
9. Blood Tests: Blood tests can help diagnose various respiratory conditions by measuring oxygen and carbon dioxide levels, identifying specific antibodies or antigens, or detecting genetic markers associated with certain diseases.
10. Positron Emission Tomography (PET) Scan: A PET scan uses a small amount of radioactive material to create detailed images of the body's internal structures and functions, helping identify areas of abnormal cell growth or metabolic activity in the lungs.

Air pollution is defined as the contamination of air due to the presence of substances or harmful elements that exceed the acceptable limits. These pollutants can be in the form of solid particles, liquid droplets, gases, or a combination of these. They can be released from various sources, including industrial processes, vehicle emissions, burning of fossil fuels, and natural events like volcanic eruptions.

Exposure to air pollution can have significant impacts on human health, contributing to respiratory diseases, cardiovascular issues, and even premature death. It can also harm the environment, damaging crops, forests, and wildlife populations. Stringent regulations and measures are necessary to control and reduce air pollution levels, thereby protecting public health and the environment.

... it is defined as chronic bronchitis. Chronic bronchitis can occur before the restricted airflow diagnostic of COPD. Some people ... Poole P, Sathananthan K, Fortescue R (May 2019). "Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive ... nonspecific chronic pulmonary disease, diffuse obstructive pulmonary syndrome. The terms emphysema and chronic bronchitis were ... Chronic bronchitis is defined as a productive cough that is present for at least three months each year for two years. Both of ...
This is typical of chronic bronchitis. Although infection is not the reason or cause of chronic bronchitis, it is seen to aid ... "Test for Acute & Chronic Bronchitis". University of Utah Healthcare. 6 April 2021. Retrieved 2021-06-12. Ward, Joel I.; Cherry ... Acute bronchitis, also known as a chest cold, is short-term bronchitis - inflammation of the bronchi (large and medium-sized ... Braman, SS (January 2006). "Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines". Chest. ...
In 1953 in a letter on Chronic Bronchitis to the British Medical Journal he wrote:'The air we breathe is as important as the ... Joules, H. (22 August 1953). "Chronic Bronchitis". British Medical Journal. 2 (4833): 440-441. doi:10.1136/bmj.2.4833.440-c. ... especially those who developed chronic bronchitis but had no radiographic evidence of pneumoconiosis. In the absence of X-ray ... Joules H. Stop that cough!: a study of preventable bronchitis. London; 1953. "Munks Roll Details for Horace Joules". munksroll. ...
... of chronic bronchitis, and otherwise stable chronic bronchitis. Stable chronic bronchitis can be defined as the normal ... NIH entry on Bronchitis MedlinePlus entries on Acute bronchitis and Chronic bronchitis Mayo Clinic factsheet on bronchitis (CS1 ... including chronic bronchitis. Decline in lung function in chronic bronchitis may be slowed by stopping smoking. Chronic ... "Chronic Bronchitis". StatPearls [Internet]. PMID 29494044. NBK482437. Chronic bronchitis ... is very often secondary to chronic ...
The most common symptom of eosinophilic bronchitis is a chronic dry cough lasting more than 6-8 weeks. Eosinophilic bronchitis ... Approximately 10-30% of people who present with a chronic cough are suspected to be symptomatic due to eosinophilic bronchitis ... Brightling CE (January 2006). "Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice ... versus eosinophilic bronchitis in asthma. Non-asthmatic eosinophilic bronchitis is different from asthma in that it does not ...
He suffered from chronic bronchitis. Besides his professional career, Adipanga was the president of the Union congolaise, the ...
He suffered from chronic bronchitis. In 1925, on the instruction of his doctors, he was reluctantly sent on a recuperative ...
Zagam (Sparfloxacin), for chronic bronchitis. Zemaira (Alpha-1 antitrypsin), for chronic augmentation, now owned by CSL Behring ... Solpadol (Codeine), for chronic pain. - Respiratory and inflammatory diseases Atrovent (Ipratropium bromide), for asthma, ... Thymoglobulin, for hemophilia A. Zemaira (Alpha-1 antitrypsin), for chronic augmentation, Now owned by CSL Behring. - ... Dupixent (Dupilumab), for eosinophilic asthma and chronic rhinosinusitis with nasal polyposis, marketed by Regeneron. Dynabac ( ...
ISBN 978-1-118-52620-0. Tamborini A (November 2016). "Maropitant & Canine Chronic Bronchitis" (PDF). Clinician's Brief. ... Maropitant has been used as an adjunct treatment in severe bronchitis due to its weak anti-inflammatory effects. It alleviates ... Some have claimed that maropitant is better at treating vomiting than nausea, pointing to cats with chronic kidney disease who ...
Most carriers of chronic bronchitis have a history of smoking. Chronic bronchitis is on a spectrum of smoking-related lung ... are known to have a side effect of chronic cough. Chronic bronchitis, an inflammation in the major airways such as the ... The prevalence of chronic cough in many communities in Europe and the U.S. is 9-33% of the population. Chronic cough is three ... An estimation of between one and 21% of children suffer from chronic cough. Causes typically diagnosed include viral bronchitis ...
"Chronic bronchitis in beedi smokers (preliminary communication)". www.popline.org. Wikimedia Commons has media related to Beedi ... A lower prevalence of chronic bronchitis and abnormal ventilatory measurements in beedi smokers, as compared with cigarette ...
Rosita Serrano, 84, Chilean singer, chronic bronchitis. Pierre-Henri Teitgen, 88, French lawyer, professor and politician. Luis ...
Asthma and Chronic Bronchitis Foundation of India. p. 288. R. Viswanathan, O. P. Jaggi (editors) (1977). Advances in chronic ... Viswanathan, R. (1975). While the Light Lives - Reminiscences of a Medical Scientist (PDF). Asthma and Chronic Bronchitis ... He was one of the founders of the Asthma and Bronchitis Foundation of India and was its president since its inception. He also ... Asthma and Bronchitis Foundation of India. p. 893. OCLC 4655837. {{cite book}}: ,author= has generic name (help) R. Viswanathan ...
"Azithromycin is effective in patients with chronic bronchitis". Journal of Antimicrobial Chemotherapy. 50 (3): 433-a-434. doi: ... publications include a 2002 sole-authorship which showed that Azithromycin is effective in patients with chronic bronchitis. ...
COPD includes emphysema as well as chronic bronchitis. Cystic fibrosis is a genetic disease, caused by a mutation that results ... Chronic obstructive pulmonary disease (COPD) is a group of diseases that results in airflow blockage and therefore cause ... "Chronic Obstructive Pulmonary Disease (COPD) , CDC". www.cdc.gov. 2023-03-20. Retrieved 2023-03-28. "Cystic fibrosis". nhs.uk. ... Another indication for the use this procedure is lung destruction due to chronic infections. During a pneumonectomy, the ...
Matteson died two months later from chronic bronchitis. He died March 30, 1896, at 60 years old, in Los Angeles County. ...
COPD [especially chronic bronchitis] may cause false readings. A noninvasive method that allows continuous measurement of the ...
... s occur in asthma, chronic bronchitis and anaphylaxis. Bronchospasms are a possible side effect of some drugs: ... Lower respiratory tract conditions such as asthma, chronic obstructive pulmonary disease (COPD), and emphysema can result in ...
COPD includes diseases such as chronic bronchitis and emphysema. The risk of lung disease from air pollution is greatest for ... "The urban factor in chronic bronchitis" Lancet 1965;I:445-448. Gauderman, W. (2007). "Effect of exposure to traffic on lung ... three towns with low reported death rates from chronic bronchitis. All subjects were male postal truck drivers aged 40 to 59. ... acute respiratory infections in children and chronic bronchitis in adults, aggravating pre-existing heart and lung disease, or ...
He died in Montreal in 1882 from chronic bronchitis. "Lewis Thomas Drummond". Dictionary of Canadian Biography (online ed.). ...
Brownish -potential indicator of chronic bronchitis (greenish/yellowish/brown); chronic pneumonia (whitish-brown); tuberculosis ... chronic infectious bronchitis, and infected bronchiectasis or cystic fibrosis. Rust colored - usually caused by pneumococcal ... The color can provide hints as to effective treatment in chronic bronchitis patients: A yellow-greenish (mucopurulent) color ... this last choice tends to suggest chronic allergic bronchitis). A white, milky, or opaque (mucoid) appearance means that ...
Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. ...
Merathi had chronic bronchitis due to heavy tobacco consumption. On 1 November 1917, he passed away at the age of 73 in Meerath ...
... bronchitis and chronic pneumonia. On 2 May 1953, Bunin left in his diary a note that proved to be his last one. "Still, this is ...
King George had suffered several bouts of serious illness since the First World War; he suffered from chronic bronchitis ...
The causes of chronic cough are similar in children with the addition of bacterial bronchitis. A cough can be the result of a ... Chronic bronchitis is defined clinically as a persistent cough that produces sputum (phlegm) and mucus, for at least three ... Chronic bronchitis is often the cause of "smoker's cough". The tobacco smoke causes inflammation, secretion of mucus into the ... Cough can also worsen in an acute exacerbation of chronic obstructive pulmonary disease. Asthma is a common cause of chronic ...
Chronic obstructive pulmonary disease is mainly a combination of chronic bronchitis and emphysema, but maybe more or less ... Chronic obstructive pulmonary disease (COPD), previously known as chronic obstructive airways disease (COAD) or chronic airflow ... Most people with COPD have characteristics of emphysema and chronic bronchitis to varying degrees. Asthma being a reversible ... Types of obstructive lung disease include; asthma, bronchiectasis, bronchitis and chronic obstructive pulmonary disease (COPD ...
His death certificate referred to chronic alcoholism and bronchitis. He and his wife Martha had eight children, four of which ...
Kasturba suffered from chronic bronchitis due to complications at birth. Her bronchitis was complicated by pneumonia. Her ... In spite of Kasturba's chronic bronchitis she continued to take part in civil actions and protests across India and often took ...
Indications include acute and chronic bronchitis, cough, rhinitis, and asthma. Adverse effects include headache, somnolence, ...
... sum of Chronic and unspecified bronchitis AND Bronchiectasis, emphysema and other chronic obstructive pulmonary disease, ... Percent of adults who have ever been diagnosed with COPD, emphysema, or chronic bronchitis: 4.6% (2022) ...
Health Information on Chronic Bronchitis: MedlinePlus Multiple Languages Collection ... Chronic Bronchitis: MedlinePlus Health Topic - English Bronquitis crónica: Tema de salud de MedlinePlus - español (Spanish) ...
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. Pulm Pharmacol Ther. 2006;19:361-9. ... Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging. 2007;24:555 ... Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis On This Page ... This patient was treated for 2 weeks with levofloxacin, 750 mg/day, for acute exacerbation of chronic bronchitis. No other ...
Learn the causes, symptoms, contagious period, treatments, and complications of chronic bronchitis. ... Chronic bronchitis is different from acute bronchitis in that it involves a cough that lasts for at least 3 months, 2 years in ... Chronic bronchitis. Chronic bronchitis differs from acute bronchitis in several ways, for example, pathology, progression of ... Top Chronic Bronchitis Related Articles. *. Bronchitis Picture. Acute bronchitis usually comes on quickly and gets better after ...
... chronic bronchitis is a common type of chronic obstructive pulmonary disease (COPD).Learn more about this condition. ... such as chronic bronchitis.. Our Aaproach to chronic bronchitis. UCSF offers comprehensive evaluations and care for all types ... Affecting millions of Americans each year, chronic bronchitis is a common type of chronic obstructive pulmonary disease (COPD) ... Cigarette smoking is the number one risk factor for developing chronic bronchitis. Over 90 percent of patients with chronic ...
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) 1984; 289 :878 doi:10.1136/bmj. ... Nocturnal deaths among patients with chronic bronchitis and emphysema.. Br Med J (Clin Res Ed) 1984; 289 doi: https://doi.org/ ...
... Chest. 1995 Dec;108(6):1557-61. doi: 10.1378/chest. ... Results: Risk of chronic bronchitis was significantly higher in current smokers than in never smokers (relative risk [RR] = ... Methods: Age-adjusted relative risk estimates for smoking categories were calculated separately for chronic bronchitis and ... chronic bronchitis risk in past smokers approached that in never smokers. In contrast, current smokers were at significantly ...
Prophylactic antibiotic therapy for chronic bronchitis. This review has been withdrawn.. The reason for withdrawal and previous ... Staykova T, Black PN, Chacko EE, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database of ...
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you dont have an account you can just enter your email address in the email box below ...
Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population Br Med J 1959; 2 :257 doi: ... Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population. Br Med J 1959; 2 doi: ... Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population ... Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population ...
What are some typical chronic bronchitis symptoms and signs? ... Chronic bronchitis is not very different from acute bronchitis ... Chronic Bronchitis Symptoms and Signs. What are some typical chronic bronchitis symptoms and signs? Bronchitis is something ... The signs and symptoms of chronic bronchitis are usually the same as those for acute bronchitis, but with chronic bronchitis, ... Smokers and Chronic Bronchitis If you smoke and have chronic bronchitis, you should know that there is no medicine that will ...
Since there is some clinical evidence that the clinical course of patients with chronic obstructive pulmonary disease (COPD) ... Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis ... Since there is some clinical evidence that the clinical course of patients with chronic obstructive pulmonary disease (COPD) ...
Acute exacerbations of chronic bronchitis (AECB) are known to have a substantial economic burden in terms of medical care costs ... Halpern, M., Polzin, J., Higashi, MK., & Bakst, A. (2004). The workplace impact of acute exacerbations of chronic bronchitis ( ... A review of the identified literature indicates that patients with chronic bronchitis had more days off work; patients whose ... The workplace impact of acute exacerbations of chronic bronchitis (AECB); A literature review ...
Chronic in Acute Exacerbation Patient Education , MIMS Singapore ... Chronic bronchitis is an infection of the trachea and bronchi ... BRONCHITIS - CHRONIC IN ACUTE EXACERBATION Patient Education *BRONCHITIS - CHRONIC IN ACUTE EXACERBATION ... It can lead to dramatic symptomatic benefits for patients with chronic bronchitis eg stopping cough in 94-100%; when coughing ... Educate patient about the nature of the chronic bronchitis (the progressive nature and its potential impact on future lifestyle ...
Byssinotics with chronic bronchitis had a significantly greater mean decrease in F.E.V.0·75 during the shift than the ... In the spinning department 40·6% of the workers had byssinosis and 15·1% had chronic bronchitis (defined as persistent cough ... Byssinosis, Chronic Bronchitis, and Ventilatory Capacities in Workers Exposed to Soft Hemp Dust ... Byssinosis, Chronic Bronchitis, and Ventilatory Capacities in Workers Exposed to Soft Hemp Dust ...
An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. ... An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. ...
Carbon Dioxide Transport in Blood and the CDH Effect in Chronic Hypoxic Bronchitis L. A. McElderry; L. A. McElderry ... L. A. McElderry, J. Walker, D. C. Flenley; Carbon Dioxide Transport in Blood and the CDH Effect in Chronic Hypoxic Bronchitis. ...
Key terms chronic bronchitis; cigarette smoking; foundry work; foundry worker; foundry worker´s pneumoconiosis; lung function; ... Chronic bronchitis was studied by means of a translation of the MRC Short Questionnarie on Respiratory Symptoms. Forced vital ... Chronic bronchitis occurred more frequently among those occupied in jobs classified as dusty. Smoking also strongly increased ... The prevalence of pneumoconiosis, chronic bronchitis, and impaired lung function was studied among those 1,000 foundry workers ...
Chronic Bronchitis Market Report provides a detailed analysis of the Chronic Bronchitis Market Size, Epidemiology, Drug ... Chronic bronchitis is an inflammation of the bronchi that lasts for a long time. Chronic bronchitis is a kind of chronic ... Chronic Bronchitis Report Highlights. *In the coming years, the Chronic Bronchitis market is set to change due to the rising ... 15.1.1. Chronic Bronchitis Total Market Size in the United States. 15.1.2. Chronic Bronchitis Market Size by Therapies in the ...
The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. ... The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. ...
... may be involved in remodeling of asthma and chronic bronchitis; its expression was compared with that of epi... ... Nineteen chronic bronchitis patients (35-71 yr, 57.3 ± 9.6 yr) were studied. Chronic bronchitis was defined according to the ... 0.0002 in chronic bronchitis, Mann-Whitney U test) (Figures 1 and 2 and Table 1). In asthma and chronic bronchitis, the TGF-β ... for inclusion in the chronic bronchitis group.. Patients with asthma or chronic bronchitis were excluded from the study if they ...
Patients typically have symptoms of both chronic bronchitis and emphysema, but the classic triad also includes asthma. ... Chronic obstructive pulmonary disease (COPD) is estimated to affect 32 million persons in the United States and is the fourth ... Chronic bronchitis. In this type, chronic bronchitis plays the major role. Chronic bronchitis is defined by excessive mucus ... Chronic obstructive pulmonary disease (COPD). Histopathology of chronic bronchitis showing hyperplasia of mucous glands and ...
Chronic bronchitis and cor pulmonale in Nepal : a monograph based on epidemiology study conducted in four areas of three ... TextPublication details: Kathmandu : Mrigendra Medical Trust, 1988. Description: 182 pSubject(s): Bronchitis -- epidemiology , ...
Adult Bronchitis, Chronic Dust Emphysema Humans Nutrition Surveys Occupational Diseases Occupational Exposure Occupations ... Chronic bronchitis and emphysema among workers exposed to dust, vapors, or fumes by industry and occupation. ... 2022). Chronic bronchitis and emphysema among workers exposed to dust, vapors, or fumes by industry and occupation. 77(7). ... "Chronic bronchitis and emphysema among workers exposed to dust, vapors, or fumes by industry and occupation" vol. 77, no. 7, ...
chronic bronchitis,. *chronic cough irritation,. *bronchogenic cancer,. *dermatitis,. *cutaneous photosensitization, and. * ... describe typical signs and symptoms of patients with chronic PAH exposure,. *describe important elements of the exposure ... Reported health effects associated with chronic exposure to coal tar and its by-products (e.g., PAHs). ... Respiratory system: cough, bronchitis, and bronchogenic cancer.. *Gastrointestinal system: leukoplakia, buccal-pharyngeal ...
Chest radiographic findings should be negative in patients with asthma or exacerbation of chronic bronchitis who do not have ... Which radiographic findings help differentiate asthma or exacerbation of chronic bronchitis from community-acquired pneumonia ( ... Underlying chronic obstructive pulmonary disease (COPD) [2] : H influenzae or M catarrhalis ... K pneumoniae CAP occurs primarily in individuals with chronic alcoholism or diabetes mellitus. P aeruginosa is a cause of CAP ...
  • With long-standing inflammation, as can be seen in chronic bronchitis, this muscular spasm and inflammation result in a fixed, nonreversible narrowing of the airway, and the condition is termed chronic obstructive pulmonary disease ( COPD ). (medicinenet.com)
  • Some NIH investigators consider chronic bronchitis a type of COPD . (medicinenet.com)
  • COPD also includes the entities of emphysema , chronic bronchitis, and chronic asthma . (medicinenet.com)
  • Statistics from the US Centers for Disease Control and Prevention (CDC) suggest that about 49% of smokers develop chronic bronchitis and 24% develop emphysema / COPD . (medicinenet.com)
  • Affecting millions of Americans each year, chronic bronchitis is a common type of chronic obstructive pulmonary disease (COPD) in which the air passages in the lungs - the bronchi - are repeatedly inflamed, leading to scarring of the bronchi walls. (ucsfhealth.org)
  • Over 90 percent of patients with chronic bronchitis have a smoking history, although only 15 percent of all cigarette smokers are ultimately diagnosed with some type of COPD, such as chronic bronchitis. (ucsfhealth.org)
  • Since there is some clinical evidence that the clinical course of patients with chronic obstructive pulmonary disease (COPD) may be complicated by thrombosis in the pulmonary vessels, we studied whether a hypercoagulability state (HS) does occur in COPD. (nih.gov)
  • Chronic bronchitis is a kind of chronic obstructive lung disease (COPD). (delveinsight.com)
  • Chronic bronchitis and emphysema are the two most common COPD diseases. (delveinsight.com)
  • Chronic obstructive pulmonary disease (COPD) is estimated to affect 32 million persons in the United States and is the fourth leading cause of death in this country. (medscape.com)
  • Patients with COPD are susceptible to many insults that can lead rapidly to an acute deterioration superimposed on chronic disease. (medscape.com)
  • Chronic obstructive pulmonary disease (COPD) is a mixture of three separate disease processes that together form the complete clinical and pathophysiological picture. (medscape.com)
  • This chronic inflammatory process is associated with tissue repair and remodeling that ultimately determines the pathologic type of COPD. (medscape.com)
  • The molecular basis for the lung inflammation seen in COPD is still an area of great research and debate, with the potential roles of cytokines, complex autoimmune processes, and immune modulation from chronic infection all under investigation. (medscape.com)
  • Chronic obstructive pulmonary disease (COPD). (medscape.com)
  • Other distinct symptoms to look out for in addition to shortness of breath when exerting yourself include: Emphysema and chronic bronchitis are two of the most common lung diseases that fall under COPD. (pti-cosmetics.com)
  • They're part of a disorder known as chronic obstructive pulmonary disease (COPD). (pti-cosmetics.com)
  • Two people may both have COPD, but one person may have symptoms more compatible with chronic bronchitis while the other person may have more symptoms of emphysema. (pti-cosmetics.com)
  • COPD or chronic obstructive pulmonary disease is often used to describe a person with chronic bronchitis, emphysema, or a mixture of both. (pti-cosmetics.com)
  • It is a type of chronic obstructive pulmonary disease (COPD) and can have a significant impact on lung health and function. (inspectnet.net)
  • Burial insurance for chronic bronchitis or COPD is a crucial consideration that deserves thoughtful planning and understanding. (insuranceforburial.com)
  • Given that chronic bronchitis has no cure and can lead to other types of chronic lung diseases, most burial or final expense insurance companies will have strict rules and guidelines for assessing an applicant with COPD. (insuranceforburial.com)
  • There are a lot of final expense insurance companies out there that don't want to do anything with chronic bronchitis or any COPD- in any case, that's why getting in touch with a highly experienced insurance agent is essential. (insuranceforburial.com)
  • Chronic lung disease will definitely come up in the underwriting process or be specific and mention COPD. (insuranceforburial.com)
  • Burial or final expense insurers will directly ask about COPD like chronic bronchitis, simply because it is one of the leading chronic diseases that cause death in the country and it has no cure. (insuranceforburial.com)
  • Also, with some insurers, if you are in the severe stages of your chronic bronchitis COPD, they will directly reject your application day one coverage. (insuranceforburial.com)
  • When chronic bronchitis progresses to include the pathologic changes of emphysema, it is often referred to as COPD. (pharmacymedicinedrugs.com)
  • The National Library of Medicine describe it as a type of chronic obstructive pulmonary disease (COPD) in which the bronchial tubes produce a lot of mucus. (medicalnewstoday.com)
  • The Centers for Disease Control and Prevention (CDC) note that a person who develops emphysema alongside chronic bronchitis will receive a diagnosis of COPD. (medicalnewstoday.com)
  • Emphysema and chronic bronchitis are lung conditions under the term chronic obstructive pulmonary disease (COPD). (xtraas.nl)
  • This and chronic (or long-term) bronchitis are the two main components of COPD. (xtraas.nl)
  • COPD (short for chronic obstructive pulmonary disease) is a progressive inflammatory lung condition that slowly restricts airflow, making it harder to breathe over time. (healthpartners.com)
  • COPD is a chronic (long-term) disease, but there are ways to help prevent it - primarily by not smoking or quitting smoking. (healthpartners.com)
  • The two main forms of COPD are chronic bronchitis and emphysema. (healthpartners.com)
  • COPD is the term for two progressive respiratory conditions, chronic bronchitis and emphysema. (healthpartners.com)
  • Chronic Obstructive Pulmonary Disease (COPD) is a widespread respiratory condition that affects millions of people globally. (ulearnonline.ca)
  • Chronic Bronchitis, a type of COPD, is characterized by persistent inflammation and irritation of the bronchial tubes, responsible for carrying air to and from the lungs. (ulearnonline.ca)
  • One of the most common respiratory diseases is Chronic Obstructive Pulmonary Disease (COPD), which is an umbrella condition that includes two serious diseases: chronic bronchitis and emphysema. (lptmedical.com)
  • COPD, or chronic obstructive pulmonary disease, is a progressive nonreversible disease that makes it hard to breathe. (cdc.gov)
  • A recent study, Chronic Obstructive Pulmonary Disease and U.S. Workers: Prevalence, Trends, and Attributable Cases Associated with Work , examined COPD prevalence, trends and the proportion of cases attributable to work, during 2012-2018 among workers looking at smoking status, industry, and occupation. (cdc.gov)
  • Your doctor may recommend a chest X-ray to diagnose chronic bronchitis and to see if you have chronic obstructive pulmonary disease (COPD). (khealth.com)
  • Chronic bronchitis is a type of chronic obstructive pulmonary disease (COPD) characterized by the persistent inflammation of your lungs' airways, called bronchi. (healthline.com)
  • Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. (wikipedia.org)
  • The two most common types of COPD are emphysema and chronic bronchitis and have been the two classic COPD phenotypes. (wikipedia.org)
  • Chronic bronchitis does not always result in airflow limitation but in young adults who smoke the risk of developing COPD is high. (wikipedia.org)
  • Many definitions of COPD in the past included emphysema and chronic bronchitis, but these have never been included in GOLD report definitions. (wikipedia.org)
  • Emphysema and chronic bronchitis remain the predominant phenotypes of COPD but there is often overlap between them and a number of other phenotypes have also been described. (wikipedia.org)
  • A cardinal symptom of COPD is the chronic and progressive shortness of breath which is most characteristic of the condition. (wikipedia.org)
  • The most often first symptom of COPD is a chronic cough, which may or may not be productive of mucus as phlegm. (wikipedia.org)
  • Chronic bronchitis is defined as a cough that occurs every day with sputum production that lasts for at least 3 months, 2 years in a row. (medicinenet.com)
  • People with chronic bronchitis develop a persistent mucus-producing cough that is present most days of the month, or for three months of the year for two successive years. (ucsfhealth.org)
  • People who suffer from chronic bronchiti s may notice times when their cough gets worse and they begin to feel even more poorly. (all4naturalhealth.com)
  • If you smoke and you cough, it s likely that your smoker s cough is actually chronic bronchitis. (all4naturalhealth.com)
  • In the spinning department 40·6% of the workers had byssinosis and 15·1% had chronic bronchitis (defined as persistent cough and phlegm on most days for as much as three months each year during the last two years). (bmj.com)
  • Respiratory system: cough, bronchitis, and bronchogenic cancer. (cdc.gov)
  • Chronic bronchitis is defined as excessive mucus secretion in the bronchi and a chronic or recurrent mucus-producing cough that lasts three or more months and recurs year after year. (aarogya.com)
  • People with chronic bronchitis often have a cough and make mucus for many years before they have shortness of breath. (tidelandshealth.org)
  • Have a cough and excessive mucus production on most days for at least three months, two years in a row, Other causes of symptoms are ruled out, like tuberculosis, Symptoms can come and go with chronic bronchitis, but the condition is a constant struggle for. (pti-cosmetics.com)
  • As your chronic cough and airway swelling from chronic inflammation worsens, catching your breath may be more difficult. (pti-cosmetics.com)
  • Recurrent cough, chronic bronchitis, and respiratory disease subsequent to initial employment at the factory were also frequently reported. (cdc.gov)
  • Symptoms of bronchitis include a cough, wheezing, and difficulty breathing. (medicalnewstoday.com)
  • A person with bronchitis may have a cough that lasts for several weeks or even a few months if the bronchial tubes take a long time to heal fully. (medicalnewstoday.com)
  • However, bronchitis is not the only condition that causes a cough. (medicalnewstoday.com)
  • One definition states that a person has chronic bronchitis if they have a daily, productive cough for at least 3 months of the year, 2 or more years in a row. (medicalnewstoday.com)
  • In the earlier stages of chronic bronchitis, the sufferer will usually begin experiencing a dry cough, one that usually occurs most in the morning time. (healthcare-journal.com)
  • Patients with chronic bronchitis will have symptoms such as shortness of breath, chronic cough, excessive mucus production and wheezing which can lead to pulmonary hypertension. (xtraas.nl)
  • Although shortness of breath and fatigue are two of the most common symptoms, there can be a chronic cough. (xtraas.nl)
  • The chronic inflammation leads to excessive mucus production, resulting in a persistent cough that lasts for at least three months in two consecutive years. (ulearnonline.ca)
  • Persistent cough: A chronic and productive cough, often accompanied by mucus or phlegm. (ulearnonline.ca)
  • Symptoms include breathlessness and a chronic, phlegmy cough that either refuse to go away or keep coming back over the course of many years. (lptmedical.com)
  • If you think you have bronchitis, you may find yourself coughing up thick and discolored mucus or developing a cough headache . (khealth.com)
  • Acute bronchitis is often called a chest cold, with its first symptom usually being a dry cough. (khealth.com)
  • A chronic cough is defined as a cough that lasts six weeks or longer. (lungandsleepspecialists.com)
  • Air becomes trapped in the lungs, resulting in wheezing, shortness of breath, and a chronic cough. (healthline.com)
  • Chronic bronchitis is defined as a productive cough that is present for at least three months each year for two years. (wikipedia.org)
  • A chronic productive cough is the result of mucus hypersecretion and when it persists for more than three months each year for at least two years, it is defined as chronic bronchitis. (wikipedia.org)
  • Chronic Bronchitis is defined as a cough for at least 3 months during each of the preceding 2 years. (careinternet.net)
  • Acute bronchitis usually last 1-3 weeks and is treated with cough medicines and decongestants. (careinternet.net)
  • Among 74,072 women, 34 to 68 years of age, who were free of major diseases, we documented 671 incident asthma cases and 798 incident cases of chronic bronchitis during 10 years of follow-up. (nih.gov)
  • Age-adjusted relative risk estimates for smoking categories were calculated separately for chronic bronchitis and asthma. (nih.gov)
  • A significant correlation was found between the number of epithelial or submucosal cells expressing TGF- β in both asthma and chronic bronchitis and basement membrane thickness and fibroblast number. (atsjournals.org)
  • By combining in situ hybridization and immunohistochemistry, it was found that eosinophils and fibroblasts were synthetizing TGF- β in asthma and bronchitis. (atsjournals.org)
  • These data suggest that TGF- β , but not EGF or GM-CSF, is involved in airways remodeling in asthma and chronic bronchitis. (atsjournals.org)
  • Asthma is a chronic inflammatory disease associated with remodeling of the airways ( 1 ) as shown by subepithelial fibrosis ( 2 ) and by the activation of fibroblasts and myofibroblasts ( 3 ). (atsjournals.org)
  • Patients typically have symptoms of both chronic bronchitis and emphysema, but the classic triad also includes asthma. (medscape.com)
  • These processes are chronic bronchitis , emphysema and, to a lesser extent, asthma . (medscape.com)
  • Asthma, obesity and smoking all complicate and worsen chronic bronchitis. (aarogya.com)
  • Also, underlying disease processes (for example, asthma, cystic fibrosis, immunodeficiency, congestive heart failure, familial genetic predisposition to bronchitis, and congenital or acquired dilation of the bronchioles) may cause chronic bronchitis to develop , but these are infrequent causes compared to cigarette smoking. (pharmacymedicinedrugs.com)
  • Public surveys illustrating patterns of ital status), chronic health problems (in- tobacco use and laying emphasis on factors cluding hypertension, diabetes, bronchial influencing smoking behaviour have been asthma, ischaemic heart disease and rheu- identified as areas of research priority for matic heart disease) and level of physical developing countries and an important activity. (who.int)
  • Acute bronchitis should not lead to other health issues like pneumonia unless you suffer from asthma or another chronic lung disease. (khealth.com)
  • Asthma is a chronic lung condition characterized by inflammation and narrowing of the airways, making breathing difficult. (healthline.com)
  • Asthma and post nasal drip from inflamed sinuses can also cause chronic bronchitis. (careinternet.net)
  • Fluoroquinolones (FQs) that are active against streptococcal species (e.g., levofloxacin and moxifloxacin) have been recommended by numerous national health authorities and international organizations for treating acute exacerbations of chronic bronchitis and pneumonia in adults ( 1 ). (cdc.gov)
  • Acute exacerbations of chronic bronchitis (AECB) are known to have a substantial economic burden in terms of medical care costs. (rti.org)
  • This patient was treated for 2 weeks with levofloxacin, 750 mg/day, for acute exacerbation of chronic bronchitis. (cdc.gov)
  • GBS is an unusual cause of acute bacterial exacerbation of chronic bronchitis compared with other respiratory pathogens such as S . pneumoniae, but pathologies associated with this bacterium are changing. (cdc.gov)
  • Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin. (empowher.com)
  • In the case of chronic bronchitis, fixed airway obstruction, airway inflammation, and retained secretions can result in a mismatch of blood flow and airflow in the lungs . (medicinenet.com)
  • Quitting smoking is also essential for patients with chronic bronchitis, since continuing to use tobacco will only further damage the lungs. (ucsfhealth.org)
  • Inhaled as aerosol sprays or taken orally, bronchodilator medications may help to relieve symptoms of chronic bronchitis by relaxing and opening the air passages in the lungs. (ucsfhealth.org)
  • However, for some, it can become a chronic condition that is usually brought on by things like smoking or continued exposure to certain chemicals that can irritate the lungs. (all4naturalhealth.com)
  • How Does Chronic Bronchitis Affect the Lungs? (inspectnet.net)
  • Chronic bronchitis is a respiratory condition characterized by inflammation and irritation of the bronchial tubes, which carry air to and from the lungs. (inspectnet.net)
  • In this article, we will explore how chronic bronchitis affects the lungs, its causes, symptoms, diagnosis, and provide answers to frequently asked questions. (inspectnet.net)
  • While acute bronchitis is usually temporary and resolves on its own, chronic bronchitis is a progressive condition that can lead to permanent damage to the lungs. (inspectnet.net)
  • Chronic bronchitis can have detrimental effects on the lungs, progressively impacting their structure and function. (inspectnet.net)
  • People with bronchitis have swelling and inflammation in their bronchial tubes, the air passages that link the mouth and nose with the lungs. (medicalnewstoday.com)
  • Bronchitis occurs when there is an infection of the bronchial tree, which is made up of the different tubes that work by carrying air to your lungs. (healthcare-journal.com)
  • Healthy lungs are made up of … How much do you know about long-term, or chronic, lung conditions? (xtraas.nl)
  • Regardless, the diagnosis of either chronic bronchitis or emphysema requires a thorough medical history, physical examination, and a simple breath test called spirometry, which measures how well your lungs are functioning. (xtraas.nl)
  • Chronic bronchitis is a long-term respiratory condition that affects the lungs. (xtraas.nl)
  • Emphysema Definition Emphysema is a chronic respiratory disease where there is over-inflation of the air sacs (alveoli) in the lungs, causing a decrease in lung function, and often, breathlessness. (xtraas.nl)
  • Chronic bronchitis causes inflammation in the bronchioles of the lungs. (xtraas.nl)
  • As both conditions affect the lungs, both chronic bronchitis and emphysema are marked by similar symptoms of shortness of breath and wheezing, but there are some differences, particularly in the late stages of the diseases. (xtraas.nl)
  • Chronic bronchitis is a condition that results from repeated irritation in the lungs' airways (called bronchial tubes or bronchioles). (healthpartners.com)
  • Bronchitis is an inflammation or swelling of the bronchial tubes (bronchi), the air passages between the mouth and nose and the lungs. (trdoctor.com)
  • Chronic bronchitis occurs because of irritation in the bronchial tubes, which are the airways that carry air to and from your lungs when you breathe. (lptmedical.com)
  • While chronic bronchitis is a result of damage and obstruction in the bronchial tubes, emphysema occurs as a result of damage in the lungs. (lptmedical.com)
  • When the lining of the bronchial tube becomes irritated and inflamed, it generates excess mucus in the lungs-triggering symptoms of bronchitis. (khealth.com)
  • Stomach acid backing up through the esophagus and into the lungs (gastro-esophageal reflux) can occasionally cause chronic bronchitis. (careinternet.net)
  • In rare cases, you may actually be experiencing symptoms of: Additionally, it's not uncommon for people to be diagnosed with both emphysema and chronic bronchitis at the same time. (pti-cosmetics.com)
  • Many people, even doctors, sometimes confuse the signs of emphysema and chronic bronchitis. (lptmedical.com)
  • This article will show you how to differentiate the signs and symptoms of emphysema and chronic bronchitis and help you understand the different treatments and medications that are effective for fighting these diseases. (lptmedical.com)
  • Patients with chronic bronchitis should receive a flu shot annually and pneumonia shot every five to seven years to prevent infections. (ucsfhealth.org)
  • Tobacco smoking and second - hand tobacco smoke exposure, repeated exposure to pollutants (especially airborne materials such as ammonia, sulphur dioxide, chlorine, bromine, hydrogen sulphide), dust, repeated attack of acute bronchitis or pneumonia, and gastric reflux (by inhalation of gastric contents). (pharmacymedicinedrugs.com)
  • Bronchitis feels more severe than a cold, but not as severe as pneumonia . (khealth.com)
  • If you have chronic bronchitis, you may need a chest X-ray to confirm that you do not have pneumonia or a serious lung disease. (khealth.com)
  • Ceftin is available as a generic drug and is prescribed to treat infections with susceptible bacteria including skin and middle ear infections, tonsillitis , throat infections, laryngitis , bronchitis , pneumonia , urinary tract infections, and gonorrhea . (rxlist.com)
  • Chronic bronchitis causes shortness of breath, coughing, excess mucus and other pulmonary symptoms. (healthpartners.com)
  • if you suffer from anything chronic, it means that it lasts for three months or more. (all4naturalhealth.com)
  • Chronic bronchitis is an inflammation of the bronchi that lasts for a long time. (delveinsight.com)
  • Acute bronchitis lasts for a specific length of time. (medicalnewstoday.com)
  • When compared, this form of bronchitis is much worse than the other form of it - known as acute bronchitis, and this is largely because chronic bronchitis usually lasts more a much longer period of time, usually weeks or months, even years. (healthcare-journal.com)
  • Acute bronchitis only lasts a few days or weeks, but chronic bronchitis lasts a lifetime. (lptmedical.com)
  • I'll also outline how long each type of bronchitis lasts, and discuss recommended methods of treatment. (khealth.com)
  • Chronic bronchitis lasts much longer than acute bronchitis, and is usually caused by constant exposure to air pollutants and cigarette smoke. (khealth.com)
  • Bronchitis is a term that describes inflammation of the bronchial tubes (bronchi and the smaller branches termed bronchioles ) that results in excessive secretions of mucus into the tubes, leading to tissue swelling that can narrow or close off bronchial tubes. (medicinenet.com)
  • Chronic coughing develops as the body attempts to open and clear the bronchial airways of particles and mucus or as an overreaction to ongoing inflammation. (medicinenet.com)
  • its expression was compared with that of epidermal growth factor (EGF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in bronchial mucosal biopsies from 13 normal subjects, 24 asthmatics, and 19 patients with chronic bronchitis. (atsjournals.org)
  • REID L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. (pti-cosmetics.com)
  • Chronic bronchitis is primarily caused by inhaling irritants that irritate and inflame the bronchial tubes over time. (inspectnet.net)
  • The chronic inflammation in the bronchial tubes results in swelling and narrowing of the airways. (inspectnet.net)
  • Bronchitis happens when a virus, bacteria, or irritant particles trigger an inflammation of the bronchial tubes. (medicalnewstoday.com)
  • Many different factors are considered as potential causes of bronchitis, but it is usually always caused by viruses that attack the lining of the bronchial tree and then which end up causing infection. (healthcare-journal.com)
  • It comes an excessive amount of bronchial mucus, a symptom that is not present with acute bronchitis. (healthcare-journal.com)
  • The primary pathology behind Chronic Bronchitis involves chronic irritation and inflammation of the bronchial tubes. (ulearnonline.ca)
  • When these viruses affect the lining of the bronchial tubes, your cold or flu can develop into bronchitis. (khealth.com)
  • Bronchitis causes inflammation in the lining of the bronchial tubes. (lungandsleepspecialists.com)
  • However, smoking and exposure to other respiratory toxins can cause chronic bronchitis, a much more serious condition in which bronchitis symptoms keep coming back and last for months or years at a time. (lptmedical.com)
  • Typically, doctors don't diagnose chronic bronchitis unless you've had three or more episodes of bronchitis in one year. (pti-cosmetics.com)
  • To diagnose chronic bronchitis, healthcare professionals may perform a thorough physical examination, review the patient's medical history, and order diagnostic tests such as pulmonary function tests, chest X-rays, and sputum analysis. (inspectnet.net)
  • Many of the bronchi develop chronic inflammation with swelling and excess mucus production. (medicinenet.com)
  • Chronic bronchitis is an infection of the trachea and bronchi for at least three consecutive months for more than two consecutive years. (mims.com)
  • Chronic bronchitis is long-term inflammation of the bronchi. (tidelandshealth.org)
  • Bronchitis is inflammation of the bronchi. (empowher.com)
  • Most cases of bronchitis develop when an infection irritates and inflames the bronchi, causing them to produce more mucus than usual. (respelearning.scot)
  • Recurrent incidences of acute bronchitis are the first steps that can lead to developing chronic bronchitis, according to some doctors and researchers. (medicinenet.com)
  • Viral and bacterial infections that result in acute bronchitis may lead to chronic bronchitis if people have repeated bouts with infectious agents. (medicinenet.com)
  • This usually means that they have gotten acute bronchitis, either bacterial or viral, on top of the chronic bronchitis they already have. (all4naturalhealth.com)
  • However, if chronic bronchitis is caused by an underlying respiratory infection, such as a viral or bacterial infection, that infection may be contagious. (inspectnet.net)
  • If bronchitis is due to a viral or bacterial infection, it is possible to transmit the infection to another person through droplets when coughing. (medicalnewstoday.com)
  • Similar to the common cold, acute bronchitis is caused by a viral upper respiratory infection. (khealth.com)
  • There are two types of bronchitis: Acute and Chronic Bronchitis. (khealth.com)
  • Chronic bronchitis is a long-term condition that involves persistent coughing, excessive mucus production, and difficulty breathing. (inspectnet.net)
  • Acute bronchitis usually clears up, but chronic bronchitis is persistent and never completely goes away. (medicalnewstoday.com)
  • In making a diagnosis of chronic bronchitis, your doctor will begin by conducting a thorough physical examination, recording your medical history and asking about any symptoms you are experiencing. (ucsfhealth.org)
  • Chest X-rays can help confirm a diagnosis of chronic bronchitis and rule out other lung conditions. (ucsfhealth.org)
  • Nocturnal deaths among patients with chronic bronchitis and emphysema. (bmj.com)
  • A literature search was conducted to identify relevant articles assessing one or more aspects of work loss or workplace costs among patients with chronic bronchitis. (rti.org)
  • Chronic bronchitis is defined by excessive mucus production with airway obstruction and notable hyperplasia of mucus-producing glands, as depicted in the images below. (medscape.com)
  • The most prevalent, however, are acute and chronic. (delveinsight.com)
  • Brontex Tablets are used for loosening phlegm in the case of acute and chronic bronchopulmonary diseases accompanied by productive coughing. (heatlhypill.com)
  • Brontex Tablets help loosen phlegm in cases of acute and chronic bronchopulmonary diseases accompanied by productive coughing. (heatlhypill.com)
  • If you have chronic bronchitis because you are constantly exposed to lung irritating chemicals, then the only way to make your symptoms stop is to avoid further exposure to those substances - there are no two ways about it. (all4naturalhealth.com)
  • The prevalence of pneumoconiosis, chronic bronchitis, and impaired lung function was studied among those 1,000 foundry workers (response rate 93.1%) with the longest exposure time (minimum 4.2, mean 17, SD 9 years) from a representative sample of 20 foundries. (sjweh.fi)
  • Other factors that can contribute to the development of chronic bronchitis include long-term exposure to air pollution, occupational hazards, genetic predisposition, and respiratory infections. (inspectnet.net)
  • Most cases of chronic bronchitis are caused by smoking cigarettes or other tobacco products, although other examples of noxious agents include fumes from cleaning products and solvents, dust from occupational exposure, and air pollution. (pharmacymedicinedrugs.com)
  • However, chronic bronchitis and emphysema have been reported as a result of phosgene exposure. (cdc.gov)
  • The goal of therapy for chronic bronchitis is to relieve symptoms, prevent complications and slow the progression of the disease. (ucsfhealth.org)
  • Staykova T, Black PN, Chacko EE, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. (cochrane.org)
  • This is a broad classification of lung diseases that includes chronic bronchitis. (delveinsight.com)
  • chronic obstructive pulmonary disease), which refers to a group of progressive lung diseases that affect the respiratory system-making it increasingly difficult to breathe. (pti-cosmetics.com)
  • By doing this, not only will you be safeguarding yourself against bronchitis and other respiratory diseases, but you will be becoming healthier overall. (healthcare-journal.com)
  • These two diseases share many early symptoms and share the fact that they are chronic, incurable respiratory conditions. (lptmedical.com)
  • Both chronic bronchitis and emphysema are serious, life-threatening diseases with no known cure. (lptmedical.com)
  • Chronic bronchitis is another chronic obstructive disease of the airways in which inflammation is a continuous process probably commencing with an increase in inflammatory cells ( 4 ) and followed by airway remodeling with extracellular matrix deposition on the airways wall ( 5 ). (atsjournals.org)
  • To evaluate the role of growth factors in the pathogenesis of airway remodeling, a study was undertaken to study the expression of a known fibrogenic growth factor (TGF-β), of a putative fibrogenic growth factor (EGF) and of a hematopoietic growth factor (GM-CSF) in the central airways of asthmatic and chronic bronchitis patients using immunohistochemistry. (atsjournals.org)
  • The tiny hair-like structures called cilia, which line the airways and help remove mucus and foreign particles, become damaged by chronic bronchitis. (inspectnet.net)
  • As well during the earlier stages of chronic bronchitis, it is usually only the larger airways that are affected, however as the disease progresses and becomes worse, all airways eventually wind up becoming involved, and over time, the patient will experience abnormal ventilation-perfusion. (healthcare-journal.com)
  • But with early detection and treatment, you can slow down the damage that chronic bronchitis does to your airways and prevent more serious complications. (lptmedical.com)
  • Smoking causes chronic irritation and inflammation, making it more likely for precancerous cells to progress to cancer. (healthline.com)
  • The Chronic Bronchitis market report provides current treatment practices, emerging drugs, Chronic Bronchitis market share of the individual therapies, current and forecasted Chronic Bronchitis market Size from 2019 to 2032 segmented by seven major markets. (delveinsight.com)
  • The disease epidemiology covered in the report provides historical as well as forecasted Chronic Bronchitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032. (delveinsight.com)
  • 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451362/all/Mucolytic_agents_for_chronic_bronchitis. (unboundmedicine.com)
  • Wheezing and fatigue are also chronic bronchitis symptoms. (all4naturalhealth.com)
  • This is why people who suffer from bronchitis find it difficult to breathe and often have serious wheezing and congestion problems. (healthcare-journal.com)
  • They also may have episodes of acute bronchitis, when symptoms are worse due to a respiratory infection, such as a cold. (tidelandshealth.org)
  • Chronic bronchitis is diagnosed after you experience several episodes of acute bronchitis in a short period of time. (pti-cosmetics.com)
  • What causes chronic bronchitis? (tidelandshealth.org)
  • Currently chronic bronchitis is treated with antibiotics, steroids, and bronchodilator inhalers.When gastro-esophageal reflux causes chronic bronchitis drugs that decrease stomach acid are used. (careinternet.net)
  • Although people of any age can develop chronic bronchitis, the majority of people diagnosed with the disease are 45 years of age or older. (medicinenet.com)
  • Antibiotics may be used to help fight respiratory infections common in people with chronic bronchitis. (ucsfhealth.org)
  • In diagnosing chronic bronchitis, it is important to rule out heart disease, lung infections, cancer and other disorders that may produce bronchitis-like symptoms. (aarogya.com)
  • People with chronic bronchitis tend to get lung infections more easily. (tidelandshealth.org)
  • Additionally, genetic predisposition and respiratory infections can increase an individual's susceptibility to Chronic Bronchitis. (ulearnonline.ca)
  • There are many causes of chronic bronchitis, but the main cause is cigarette smoke. (medicinenet.com)
  • Cigarette smoking is the number one risk factor for developing chronic bronchitis. (ucsfhealth.org)
  • Cigarette smoking is thought to be the leading cause of chronic bronchitis. (delveinsight.com)
  • Most experts agree that the main cause of chronic bronchitis is cigarette smoking. (tidelandshealth.org)
  • We sometimes evaluate new drugs for the treatment of acute bronchitis. (careinternet.net)
  • Approximately 5 years after quitting, chronic bronchitis risk in past smokers approached that in never smokers. (nih.gov)
  • Chronic bronchitis symptoms that are distinct to the condition include: Emphysema is a progressive lung disease that most commonly affects smokers and people who regularly breathe in irritants. (pti-cosmetics.com)
  • If you feel like your seasonal cold is worse than usual-for instance, if you're experiencing excessive coughing, yellow-like mucus, a sore throat, and other severe cold-like symptoms-you may actually have bronchitis. (khealth.com)
  • When treating chronic bronchitis, we aim to ease symptoms, slow progression of the disease and prevent complications. (ucsfhealth.org)
  • Hypercoagulability state in patients with chronic obstructive pulmonary disease. (nih.gov)
  • The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. (bmj.com)
  • Other insurers may refer to it as chronic respiratory disease, chronic lower respiratory disease on which you have to answer yes. (insuranceforburial.com)
  • There are no surefire methods of preventing yourself from ever getting bronchitis, but there are certainly preventive measures that you can take in order to guard yourself against the disease as much as possible. (healthcare-journal.com)
  • Chronic bronchitis is one of the most commonly occurring upper respiratory conditions in the world, and one of the most potentially dangerous as well, and so it is really important that you take the situation seriously and take every step possible towards protecting yourself and preventing your body from developing the disease. (healthcare-journal.com)
  • Acute bronchitis is a common, short-term condition that otherwise healthy people can get, and it's usually the result of a respiratory infection. (lptmedical.com)
  • On very rare occasions, your acute bronchitis may be caused by a bacterial infection. (khealth.com)
  • Lung volume reduction surgery, during which small wedges of damaged lung tissue are removed, may be recommended for some patients with chronic bronchitis. (ucsfhealth.org)
  • An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. (bmj.com)
  • Paramedics play a crucial role in the early assessment and management of patients with Chronic Bronchitis. (ulearnonline.ca)
  • In severe cases, patients may battle chronic bronchitis annually. (khealth.com)
  • Symptoms will depend on the type of bronchitis. (empowher.com)
  • A few authors include the trachea and upper airway in the definition of bronchitis . (medicinenet.com)
  • Histopathology of chronic bronchitis showing hyperplasia of mucous glands and infiltration of the airway wall with inflammatory cells. (medscape.com)